key: cord-0017331-la04euhc authors: Shi, Chunhu; Dumville, Jo C; Cullum, Nicky; Rhodes, Sarah; Jammali-Blasi, Asmara; McInnes, Elizabeth title: Alternating pressure (active) air surfaces for preventing pressure ulcers date: 2021-05-10 journal: Cochrane Database Syst Rev DOI: 10.1002/14651858.cd013620.pub2 sha: 2b694d848a9058cc47ad9dc88db9d4d0c73ae4b2 doc_id: 17331 cord_uid: la04euhc BACKGROUND: Pressure ulcers (also known as pressure injuries, pressure sores, decubitus ulcers and bed sores) are localised injuries to the skin or underlying soft tissue, or both, caused by unrelieved pressure, shear or friction. Alternating pressure (active) air surfaces are widely used with the aim of preventing pressure ulcers. OBJECTIVES: To assess the effects of alternating pressure (active) air surfaces (beds, mattresses or overlays) compared with any support surface on the incidence of pressure ulcers in any population in any setting. SEARCH METHODS: In November 2019, we searched the Cochrane Wounds Specialised Register; the Cochrane Central Register of Controlled Trials (CENTRAL); Ovid MEDLINE (including In‐Process & Other Non‐Indexed Citations); Ovid Embase and EBSCO CINAHL Plus. We also searched clinical trials registries for ongoing and unpublished studies, and scanned reference lists of relevant included studies as well as reviews, meta‐analyses and health technology reports to identify additional studies. There were no restrictions with respect to language, date of publication or study setting. SELECTION CRITERIA: We included randomised controlled trials that allocated participants of any age to alternating pressure (active) air beds, overlays or mattresses. Comparators were any beds, overlays or mattresses. DATA COLLECTION AND ANALYSIS: At least two review authors independently assessed studies using predetermined inclusion criteria. We carried out data extraction, 'Risk of bias' assessment using the Cochrane 'Risk of bias' tool, and the certainty of the evidence assessment according to Grading of Recommendations, Assessment, Development and Evaluations methodology. MAIN RESULTS: We included 32 studies (9058 participants) in the review. Most studies were small (median study sample size: 83 participants). The average age of participants ranged from 37.2 to 87.0 years (median: 69.1 years). Participants were largely from acute care settings (including accident and emergency departments). We synthesised data for six comparisons in the review: alternating pressure (active) air surfaces versus: foam surfaces, reactive air surfaces, reactive water surfaces, reactive fibre surfaces, reactive gel surfaces used in the operating room followed by foam surfaces used on the ward bed, and another type of alternating pressure air surface. Of the 32 included studies, 25 (78.1%) presented findings which were considered at high overall risk of bias. Primary outcome: pressure ulcer incidence Alternating pressure (active) air surfaces may reduce the proportion of participants developing a new pressure ulcer compared with foam surfaces (risk ratio (RR) 0.63, 95% confidence interval (CI) 0.34 to 1.17; I(2) = 63%; 4 studies, 2247 participants; low‐certainty evidence). Alternating pressure (active) air surfaces applied on both operating tables and hospital beds may reduce the proportion of people developing a new pressure ulcer compared with reactive gel surfaces used on operating tables followed by foam surfaces applied on hospital beds (RR 0.22, 95% CI 0.06 to 0.76; I(2) = 0%; 2 studies, 415 participants; low‐certainty evidence). It is uncertain whether there is a difference in the proportion of people developing new pressure ulcers between alternating pressure (active) air surfaces and the following surfaces, as all these comparisons have very low‐certainty evidence: (1) reactive water surfaces; (2) reactive fibre surfaces; and (3) reactive air surfaces. The comparisons between different types of alternating pressure air surfaces are presented narratively. Overall, all comparisons suggest little to no difference between these surfaces in pressure ulcer incidence (7 studies, 2833 participants; low‐certainty evidence). Included studies have data on time to pressure ulcer incidence for three comparisons. When time to pressure ulcer development is considered using a hazard ratio (HR), it is uncertain whether there is a difference in the risk of developing new pressure ulcers, over 90 days' follow‐up, between alternating pressure (active) air surfaces and foam surfaces (HR 0.41, 95% CI 0.10 to 1.64; I(2) = 86%; 2 studies, 2105 participants; very low‐certainty evidence). For the comparison with reactive air surfaces, there is low‐certainty evidence that people treated with alternating pressure (active) air surfaces may have a higher risk of developing an incident pressure ulcer than those treated with reactive air surfaces over 14 days' follow‐up (HR 2.25, 95% CI 1.05 to 4.83; 1 study, 308 participants). Neither of the two studies with time to ulcer incidence data suggested a difference in the risk of developing an incident pressure ulcer over 60 days' follow‐up between different types of alternating pressure air surfaces. Secondary outcomes The included studies have data on (1) support‐surface‐associated patient comfort for comparisons involving foam surfaces, reactive air surfaces, reactive fibre surfaces and alternating pressure (active) air surfaces; (2) adverse events for comparisons involving foam surfaces, reactive gel surfaces and alternating pressure (active) air surfaces; and (3) health‐related quality of life outcomes for the comparison involving foam surfaces. However, all these outcomes and comparisons have low or very low‐certainty evidence and it is uncertain whether there are any differences in these outcomes. Included studies have data on cost effectiveness for two comparisons. Moderate‐certainty evidence suggests that alternating pressure (active) air surfaces are probably more cost‐effective than foam surfaces (1 study, 2029 participants) and that alternating pressure (active) air mattresses are probably more cost‐effective than overlay versions of this technology for people in acute care settings (1 study, 1971 participants). AUTHORS' CONCLUSIONS: Current evidence is uncertain about the difference in pressure ulcer incidence between using alternating pressure (active) air surfaces and other surfaces (reactive water surfaces, reactive fibre surfaces and reactive air surfaces). Alternating pressure (active) air surfaces may reduce pressure ulcer risk compared with foam surfaces and reactive gel surfaces used on operating tables followed by foam surfaces applied on hospital beds. People using alternating pressure (active) air surfaces may be more likely to develop new pressure ulcers over 14 days' follow‐up than those treated with reactive air surfaces in the nursing home setting; but as the result is sensitive to the choice of outcome measure it should be interpreted cautiously. Alternating pressure (active) air surfaces are probably more cost‐effective than reactive foam surfaces in preventing new pressure ulcers. Future studies should include time‐to‐event outcomes and assessment of adverse events and trial‐level cost‐effectiveness. Further review using network meta‐analysis will add to the findings reported here. Sauvage 2017 presented data for the questionnaire's subscales as numbers and percentages, and reported no significant difference in the overall satisfaction between study groups (P = 0.21). - (1 RCT) Very low e,f It is uncertain if there is any difference in support surface-associated patient comfort between alternating pressure (active) air surfaces and foam surfaces. All reported adverse events Follow-up: range 30 days to 6 months Nixon 2019 and Sauvage 2017 reported similar rates of adverse events between their study arms. Rosenthal 2003 reported 1 death but did not specify which study group the death was associated with. -2181 (3 RCTs) It is uncertain if there is any difference in all reported adverse events between alternating pressure (active) air surfaces and foam surfaces. Health-related quality of life (90-day EQ-5D-5L, The mean health-related quality of life (90-MD 0.00 -267 (1 RCT) expressed as utility values ranging from −1 to 1 with 1 representing perfect health, 0 representing death, and −1 representing worse than death) Follow-up: 90 days day EQ-5D-5L) was 0.52. (0.05 lower to 0.05 higher) measured using EQ-5D-5L at 90day follow-up between alternating pressure (active) air surfaces and foam surfaces. Health-related quality of life (90-day PU-QoL-UI, expressed as utility values ranging from −1 to 1 with 1 representing perfect health, 0 representing death, and −1 representing worse than death) Follow-up: 90 days The mean health-related quality of life (90day PU-QoL-UI) was 0.60. MD 0.00 (0.03 lower to 0.03 higher) It is unclear if there is a difference in health-related quality of life measured using the PU-QoL-UI at 90-day follow-up between alternating pressure (active) air surfaces and foam surfaces. Cost-effectiveness Follow-up: 90 days Incremental cost-effectiveness ratio (ICER) = GBP -101699 and Net Monetary Benefit (NMB) = GBP -2114 in the probabilistic analysis, meaning alternating pressure (active) air surfaces has lower costs and higher quality-adjusted life-year (QALY) values. Alternating pressure (active) air surfaces had a 99% probability of being cost-effective at a threshold of GBP 20,000 and alternating pressure (active) air surfaces dominated reactive foam surfaces. -1 RCT ⊕⊕⊕⊝ Moderate j Alternating pressure (active) air surfaces are probably cost-effective compared with reactive foam surfaces. *The risk in the intervention group (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI). It is uncertain if there is any difference in support surface-associated patient comfort between alternating pressure (active) air surfaces and reactive air surfaces. Risk with reactive fibre surfaces Risk with alternating pressure (active) air surfaces It is uncertain if the proportion of people developing a new pressure ulcer is decreased or increased when alternating pressure (active) air surfaces are compared with reactive fibre surfaces. Time to pressure ulcer development Included studies did not report this outcome. Support surface-associated patient comfort Follow-up: 3 months. 19 dropouts among 93 people using alternating pressure (active) air surfaces; and 17 of 94 using reactive fibre surfaces with discomfort as the reason given. - (1 RCT) It is uncertain if there is any difference in support surface-associated patient comfort between alternating pressure (active) air surfaces and reactive fibre surfaces. Included studies did not report this outcome. Included studies did not report this outcome. Cost effectiveness Included studies did not report this outcome. *The risk in the intervention group (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI). CI: confidence interval; RR: risk ratio GRADE Working Group grades of evidence High certainty: we are very confident that the true effect lies close to that of the estimate of the effect. Moderate certainty: we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different. Low certainty: our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect. Very low certainty: we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect. Alternating pressure (active) air surfaces applied on both operating tables and hospital beds may reduce the proportion of people developing a new pressure ulcer compared with reactive gel surfaces used on operating tables followed by foam surfaces applied on hospital beds. Included studies did not report this outcome. Support surface-associated patient comfort Included studies did not report this outcome. All reported adverse events Follow-up: 7 days Approximately 1/2 of the participants in each group reported adverse events. No difference in adverse events between groups was reported. None of the adverse events were related to the mattresses assigned. - (1 RCT) It is uncertain if there is any difference in all reported adverse events between alternating pressure (active) air surfaces applied on both operating tables and hospital beds and reactive gel surfaces used on operating tables followed by foam surfaces applied on hospital beds. Trusted evidence. Informed decisions. Better health. Cochrane Database of Systematic Reviews Pressure ulcers (also known as pressure injuries, pressure sores, decubitus ulcers and bed sores) are localised injuries to the skin or underlying so tissue, or both, caused by unrelieved pressure, shear or friction (NPIAP 2016) . Pressure ulcer severity is generally classified using the National Pressure Injury Advisory Panel (NPIAP) system (NPIAP 2016). • Stage 1: intact skin with a local appearance of non-blanchable erythema. • Stage 2: partial-thickness skin loss with exposed dermis. • Stage 3: full-thickness skin loss. • Stage 4: full-thickness skin and tissue loss with visible fascia, muscle, tendon, ligament, cartilage or bone. • Unstageable pressure injury: full-thickness skin and tissue loss that is obscured by slough or eschar so that the severity of injury cannot be confirmed. • A deep tissue pressure injury: local injury of persistent, non-blanchable deep red, maroon, purple discolouration or epidermal separation revealing a dark wound bed or bloodfilled blister. These above stages of pressure ulcer are consistent with those described in another commonly used system: the International Classification of Diseases for Mortality and Morbidity Statistics of the World Health Organization 2019. Pressure ulcers are relatively common, complex wounds a ecting people across di erent care settings. A systematic review found that prevalence estimates for people a ected by pressure ulcers in communities of the UK, USA, Ireland, and Sweden ranged from 5.6 to 2300 per 10,000 depending on the nature of the population surveyed (Cullum 2016) . A subsequent cross-sectional survey of people receiving community health services in one city in the UK estimated that 1.8 people per 10,000 have a pressure ulcer (Gray 2018 ). Pressure ulcers confer a heavy burden in terms of personal impact and health service resource use. Having a pressure ulcer may impair physical, social and psychological activities (Gorecki 2009 ). Ulceration impairs health-related quality of life (Essex 2009); can result in longer institution stays (Theisen 2012); and increases the risk of systemic infection (Espejo 2018) . There are also substantial impacts on health systems. A 2015 systematic review of 14 studies across a range of care settings in Europe and North America, showed that pressure ulcer-related treatment costs ranged between EUR 1.71 and EUR 470.49 per person, per day (Demarré 2015) . In the UK, the annual average National Health Service cost attributable to managing one person with a pressure ulcer in the community was estimated to be GBP 1400 for a Stage 1 pressure ulcer and more than GBP 8500 for more severe stages (2015 /2016 Guest 2018) . In Australia, the annual cost of treating pressure ulcers was estimated to be AUD 983 million (95% confidence interval (CI) 815 to 1151 million) at 2012/2013 prices (Nguyen 2015) . The serious consequences of pressure ulceration have led to an intensive focus on their prevention. Pressure ulcers are considered largely preventable. Support surfaces are specialised medical devices designed to relieve or redistribute pressure on the body, or both, in order to prevent pressure ulcers (NPIAP S3I 2007) . Types of support surface include, but are not limited to, integrated bed systems, mattresses and overlays (NPIAP S3I 2007) . Classification of support surface type can now be based on the NPIAP Support Surface Standards Initiative (S3I) terms and definitions related to support surfaces (NPIAP S3I 2007) . According to the NPIAP S3I terms and definitions support surfaces may: • be powered (i.e. require electrical power to function) or nonpowered; • passively redistribute body weight (i.e. reactive pressure redistribution), or mechanically alternate the pressure on the body to reduce the duration of pressure (i.e. active pressure redistribution); • be made of a range of materials including but not limited to: aircells, foam materials, fibre materials, gel materials, sheepskin for medical use, and water-bags; • be constructed of air-filled cells that have small holes on the surface for blowing out air to dry skin (i.e. low-air-loss feature) or have fluid-like characteristics via forcing filtered air through ceramic beads (i.e. air-fluidised feature), or have neither of these features. Full details of support surface classifications are listed in Appendix 1. A widely used type of support surface is the alternating pressure (active) air bed, mattress or overlay (traditionally termed alternating pressure, or dynamic air bed, mattress or overlay). Examples of types of alternating pressure air beds, mattresses or overlays include: • powered active air mattresses (e.g. Nimbus II, MicroPulse, largecelled ripple); • powered active low-air-loss mattresses; • powered hybrid system air mattresses (e.g. TheraPulse); • powered hybrid system low-air-loss mattresses. These mattresses are made of air-cells that intermittently inflate and deflate via electrically powered pumps (Clark 2011; NPIAP S3I 2007) . Additionally, these active, alternating pressure air mattresses can have an integrated reactive element to create socalled 'hybrid' mattresses (Fletcher 2015) . Alternating pressure (active) air mattresses can have low-air-loss features designed to influence the microclimate environment by keeping the skin dry (since moisture is thought to potentially increase friction on skin and increase the risk of skin damage) (Clark 2011; Wounds International 2010). Support surfaces that can prevent pressure ulceration aim to redistribute pressure beneath the body, facilitating blood flow to tissues and preventing skin and so tissue distortion (Wounds International 2010) . Active support surfaces (e.g. alternating pressure (active) air bed, mattress or overlay) achieve pressure redistribution by frequently changing the points of contact between the surface and body, reducing the duration of the pressure applied to specific anatomical sites (Clark 2011; NPIAP S3I 2007) . This contrasts with the mode of action of reactive support surfaces, which is more passive and includes immersion (i.e. 'sinking' of the body into a support surface) and envelopment (i.e. conforming of a support surface to the irregularities of the body). These devices distribute the pressure over a greater area, thereby reducing the magnitude of the pressure at specific sites (Clark 2011). Support surfaces are widely used for pressure ulcer prevention and are the focus of recommendations in international and national guidelines (EPUAP/NPIAP/PPPIA 2019; NICE 2014). Since the publication of the Cochrane Review, 'Support surfaces for pressure ulcer prevention' (McInnes 2015) , there has been a substantial increase in the number of relevant randomised controlled trials (RCTs) published; recognition of the NPIAP S3I 2007 terms and definitions related to support surfaces; and new Cochrane methodological requirements, such as the use of GRADE assessments (Guyatt 2008) . These developments mean that it is important to update the evidence base. In considering this evidence update, we took into account the size and complexity of 'Support surfaces for pressure ulcer prevention' (McInnes 2015) , which included all support surface types. An alternative approach is to split the review into multiple new titles, each with a narrower focus. We consulted on this splitting option via an international survey in August 2019. The potential new titles suggested were based on clinical use, the new terms and definitions related to support surfaces (NPIAP S3I 2007) , a relevant network meta-analysis (Shi 2018a) , and current clinical practice guidelines (EPUAP/NPIAP/PPPIA 2019; NICE 2014). We received responses from 29 health professionals involved in pressure ulcer prevention activity in several countries (Australia, Belgium, China, Italy, the Netherlands and the UK). In total, 83% of respondents supported splitting the review into suggested titles and 17% were unsure (no respondent voted against splitting). The new review titles are: • Alternating pressure (active) air surfaces for preventing pressure ulcers; • Foam surfaces for preventing pressure ulcers; • Reactive air surfaces for preventing pressure ulcers; and • Alternative reactive support surfaces (non-foam and non-airfilled) for preventing pressure ulcers. We will bring the results of these new reviews together in an overview with a network meta-analysis (Salanti 2012) , in order to compare simultaneously all support surfaces and to rank them based on the probabilities of each being the most e ective for preventing pressure ulcers. This particular review compares alternating pressure (active) air beds, mattresses or overlays with any surface. To assess the e ects of alternating pressure (active) air surfaces (beds, mattresses or overlays) compared with any support surface on the incidence of pressure ulcers in any population in any setting. We included published and unpublished RCTs (including multiarm studies, cluster-RCTs and cross-over trials), regardless of the language in which they were reported. We also included RCTs with particular designs (factorial design, n-of-1 trial design (i.e. a randomised controlled cross-over trial in a single participant)). We excluded studies using quasi-random allocation methods (e.g. alternation). We included studies in any populations, including those defined as being at risk of ulceration, as well as those with existing pressure ulcers at baseline (when the study measured pressure ulcer incidence). This review focused on alternating pressure (active) air beds or mattresses in general. Eligible studies included a specific bed, overlay or mattress with active pressure redistribution (or alternating pressure) capabilities. These included, but were not limited to, specific active mattresses identified in Shi 2018a; namely: • powered active air mattresses (also known as alternating pressure air mattresses); or • powered active low-air-loss mattresses (also known as dynamic low-air-loss mattresses); or • powered hybrid system air mattresses (e.g. So form Premier Active air mattresses); or • powered hybrid system low-air-loss mattresses (e.g. TheraPulse ATP mattresses). In this review, we considered hybrid mattresses to be systems that incorporate both active and reactive pressure redistribution modes in a single unit and could apply either of the two modes as required by the user. For those using such hybrid mattresses, potential pressure ulcer risk reduction may result from both modes being used interchangeably over time, rather than being the result of constantly applying a single mode. We included studies where two or more support surfaces were used sequentially over time or in combination, where the support surface(s) of interest were included in one of the study arms. We included studies comparing eligible alternating pressure (active) air beds, overlays or mattresses with any comparator defined as a support surface. Comparators could be: Trusted evidence. Informed decisions. Better health. We included studies in which co-interventions (e.g. repositioning) were delivered, provided that co-interventions between a study's arms were the same (i.e. interventions randomised were the only systematic di erence). We considered the primary and secondary outcomes described below. If a study was otherwise eligible (i.e. eligible study design, participants and interventions) but did not report any reviewrelevant outcomes, we contacted the study authors where possible to clarify whether they measured a relevant outcome but did not report it. We placed the study in 'Studies awaiting classification' if we could not establish whether it measured an outcome or not. We excluded the study if the study authors confirmed that they did not measure any review-relevant outcomes. For a study that measured an outcome at multiple time points, we considered outcome measures at three months as the primary interest of this review (Schoonhoven 2007) , regardless of the time points specified as being of primary interest by the study. If the study did not report three-month outcome measures, we considered those closest to three months in this review. Where a study only reported a single time point, we considered these data in this review. Where the study did not specify a time point for their outcome measurement, we assumed this was the final duration of follow-up noted. Our primary outcome was pressure ulcer incidence. We recorded two outcome measures (the proportion of participants developing a new pressure ulcer; and time to pressure ulcer development) where available. However, we considered the proportion of participants developing a new pressure ulcer as the primary outcome for this review. Time to pressure ulcer development was our preferred measure; however, we did not expect it to be reported in many studies. We extracted and analysed time-to-event data but focused on the binary outcome in our conclusions. We accepted authors' definitions of an incident ulcer regardless of which pressure ulcer severity classification was used to measure or grade new pressure ulcers. We also considered the outcome of pressure ulcer incidence irrespective of whether studies report ulcers by stages or as a non-stratified value. We did not consider subjective outcome measures (e.g. 'better' or 'worse' skin condition) as measures of pressure ulcer incidence. • Support-surface-associated patient comfort. We considered patient comfort outcome data in this review only if the evaluation of patient comfort was pre-planned and was systematically conducted across all participants in the same way in a study. The definition and measurement of this outcome varied from one study to another; for example, the proportion of participants who report comfort, or comfort measured by a scale with continuous (categorical) numbers. We planned to include these data with di erent measurements in separate meta-analyses when possible. • All reported adverse events (measured using surveys or questionnaires, other data capture process or visual analogue scale). We included data where study authors specified a clear method for collecting adverse event data. Where available, we extracted data on all serious and all non-serious adverse events as an outcome. We recorded where it was clear that events were reported at the participant level or whether multiple events per person were reported, in which case appropriate adjustments were required for data clustering (Peryer 2019). We considered the assessment of any event in general defined as adverse by participants, health professionals, or both. • Health-related quality of life (measured using a standardised generic questionnaire such as EQ-5D (Herdman 2011), 36item Short Form (SF-36; Ware 1992) , or pressure ulcer-specific questionnaires such as the PURPOSE Pressure Ulcer Quality of Life (PU-QOL) questionnaire (Gorecki 2013), at noted time points). We did not include ad hoc measures of quality of life or qualitative interviews of quality of life because these measures were unlikely to be validated. • Cost-e ectiveness: within-trial cost-e ectiveness analysis comparing mean di erences in e ects with mean cost di erences between the two arms: we extracted data on incremental mean cost per incremental gain in benefit (incremental cost-e ectiveness ratio (ICER)). We also considered other measures of relative cost-e ectiveness (e.g. net monetary benefit, net health benefit). We searched the following electronic databases to identify reports of relevant clinical trials: Trusted evidence. Informed decisions. Better health. Search strategies for clinical trial registries can be found in Appendix 2. For previous versions of McInnes 2015, the review authors of McInnes 2015 contacted experts in the field of wound care to enquire about potentially relevant, ongoing and recently published studies. In addition, the review authors of McInnes 2015 contacted manufacturers of support surfaces for details of any studies manufacturers were conducting. This approach did not yield any additional studies; therefore, we did not repeat it for this review. We identified other potentially eligible studies or ancillary publications by searching the reference lists of retrieved included studies, as well as relevant systematic reviews, meta-analyses and health technology assessment reports. When necessary, we contacted authors of key papers and abstracts to request further information about their trials. We did not perform a separate search for adverse e ects of interventions used. We considered adverse e ects described in included studies only. We carried out data collection and analysis according to the methods stated in the published protocol (Shi 2020) , which were based on the Cochrane Handbook for Systematic Reviews of Interventions (Li 2019). Changes from the protocol or previous published versions of the review are documented in Di erences between protocol and review. One review author re-checked the RCTs included in McInnes 2015 for eligibility (CS) . Two review authors (CS and AJB, or JCD) independently assessed the titles and abstracts of the new search results for relevance using Rayyan (Ouzzani 2016) (Di erences between protocol and review) and then independently inspected the full-text of all potentially eligible studies. The two review authors (CS and AJB, or JCD) resolved disagreements through discussion and by involving a third review author if necessary. One review author checked data from the studies included in McInnes 2015 and extracted additional data where necessary (CS). A second review author or researcher (SR, AJB, EM, Zhenmi Liu, Gill Norman, or Melanie Stephens) checked any new data extracted. For new included studies, one review author (CS) independently extracted data and another review author or researcher (SR, AJB, EM, Zhenmi Liu, Gill Norman, or Melanie Stephens) checked all data (Di erences between protocol and review). We resolved any disagreements through discussion and, if necessary, with the involvement of another review author. Where necessary, we contacted the authors of included studies to clarify data. We extracted these data using a pre-prepared data extraction form: • basic characteristics of studies (first author, publication type, publication year, and country); • funding sources; • care setting; • characteristics of participants (trial eligibility criteria, average age in each arm or in a study, proportions of participants by gender, and participants' baseline skin status); • support surfaces being compared (including their descriptions); • details on any co-interventions; • follow-up duration; • the number of participants enrolled; • the number of participants randomised to each arm; • the number of participants analysed; • participant withdrawals with reasons; • the number of participants developing new ulcers (by ulcer stages where possible); • time to pressure ulceration outcome data; • patient support-surface-associated comfort; • adverse event outcome data; • health-related quality of life outcome data; and • cost-e ectiveness outcome data. We (CS and NC) classified specific support surfaces in the included studies into intervention groups using the NPIAP S3I terms and definitions related to support surface (NPIAP S3I 2007) . Therefore, to accurately assign specific support surfaces to intervention groups, we extracted full descriptions of support surfaces from included studies, and when necessary, supplemented the information with that from external sources such as other publications about the same support surface, manufacturers' or product websites, and expert clinical opinion (Shi 2018b ). If we were unable to define or classify any of the specific support surfaces evaluated in an included study, we extracted available data and reported these as additional data outside the main review results. Two review authors or researchers (CS and SR, AJB, EM, Zhenmi Liu, Gill Norman, or Melanie Stephens) independently assessed the risk of bias of each included study using the Cochrane 'Risk of bias' tool (see Appendix 3). This tool has seven specific domains: sequence generation (selection bias), allocation concealment (selection bias), blinding of participants and personnel (performance bias), blinding of outcome assessment (detection bias), incomplete data (attrition bias), selective outcome reporting (reporting bias), and other issues (Higgins 2017). We assessed performance bias, detection bias, and attrition bias for each of the review outcomes separately (Higgins 2017). We noted that it is o en impossible to blind participants and personnel in device trials. In this case, performance bias may be introduced if knowledge of treatment allocation results in deviations from intended interventions, di erential use of co-interventions or care between groups not specified in the study protocol that may influence outcomes. We attempted to understand if, and how, included studies compensated for challenges in blinding; for example, implementing strict protocols to maximise consistency of cointerventions between groups to reduce the risk of performance bias. We also noted that pressure ulcer incidence is a subjective outcome. Compared with blinded assessment, non-blinded assessment of subjective outcomes tends to be associated with more optimistic e ect estimates of experimental interventions in RCTs (Hróbjartsson 2012). Therefore, we judged non-blinded outcome assessment as being at high risk of detection bias. In this Library Trusted evidence. Informed decisions. Better health. Cochrane Database of Systematic Reviews review, we included the issues of di erential diagnostic activity and unit of analysis under the domain of 'other issues'. For example, unit of analysis issues occurred where a cluster-randomised trial had been undertaken but analysed at the individual level in the study report. For the studies included in McInnes 2015, one review author (CS) checked the 'Risk of bias' judgements and, where necessary, updated them. A second review author or researcher (SR, AJB, EM, Zhenmi Liu, Gill Norman, or Melanie Stephens) checked any updated judgement. We assigned each 'Risk of bias' domain a judgement of high, low, or unclear risk of bias. We resolved any discrepancy through discussion and by involving another review author where necessary. Where possible, useful and feasible, when a lack of reported information resulted in a judgement of unclear risk of bias, we planned to contact study authors for clarification. We present our assessment of risk of bias for the proportion of participants developing a new pressure ulcer outcome using two 'Risk of bias' summary figures. One is a summary of bias for each item across all studies, and the second shows a cross-tabulation of each study by all of the 'Risk of bias' items. Once we had given our judgements for all 'Risk of bias' domains, we judged the overall risk of bias for each outcome across studies as: • low risk of bias, if we judged all domains to be at low risk of bias; • unclear risk of bias, if we judged one or more domains to be at unclear risk of bias and other domains were at low risk of bias but no domain was at high risk of bias; or • high risk of bias, as long as we judged one or more domains as being at high risk of bias, or all domains had unclear 'Risk of bias' judgements, as this could substantially reduce confidence in the result. We resolved any discrepancy between review authors through discussion and by involving another review author where necessary. For studies using cluster randomisation, we planned to consider the risk of bias in relation to recruitment bias, baseline imbalance, loss of clusters, incorrect analysis and comparability with individually randomised studies (Eldridge 2019; Higgins 2019; Appendix 3). However, we did not include any studies with a cluster design. For meta-analysis of pressure ulcer incidence data, we present the risk ratio (RR) with its 95% confidence interval (CI). For continuous outcome data, we present the mean di erence (MD) with 95% CIs for studies that use the same assessment scale. If studies reporting continuous data used di erent assessment scales, we planned to report the standardised mean di erence (SMD) with 95% CIs. However, this was not undertaken in the review. For time-to-event data (time to pressure ulcer development), we present the hazard ratio (HR) with its 95% CI. If included studies reporting time-to-event data did not report an HR, then, when feasible, we estimated this using other reported outcomes, such as numbers of events, through employing available statistical methods (Parmar 1998; Tierney 2007) . We noted whether studies presented outcomes at the level of cluster (e.g. ward, research site) or at the level of participants. We also recorded whether the same participant was reported as having multiple pressure ulcers. Unit of analysis issues may occur if studies randomise at the cluster level but the incidence of pressure ulcers is observed and data are presented and analysed at the level of participants (clustered data). We noted whether data regarding participants within a cluster were (incorrectly) treated as independent within a study, or were analysed using within-cluster analysis methods. If clustered data were incorrectly analysed, we recorded this as part of the 'Risk of bias' assessment. If a cluster-RCT was not correctly analysed, where possible, we planned to use available information (see below) to adjust for clustering ourselves, in accordance with guidance in the Cochrane Handbook for Systematic Reviews of Interventions (Higgins 2019): • the number of clusters randomly assigned to each intervention; or the average (mean) number of participants per cluster; • outcome data ignoring the cluster design for the total number of participants; and • estimate of the intra-cluster (or intra-class) correlation coe icient (ICC). However, we did not adjust for clustering for the two studies with an n-of-1 trial design because they did not report su icient information to facilitate this. For cross-over trials, we only considered outcome data at the first intervention phase (i.e. prior to cross-over) as eligible. If a study had more than two eligible study arms, where appropriate, we combined results across these arms to make single pair-wise comparisons (Higgins 2019). Data are commonly missing from study reports. Reasons for missing data could be the exclusion of participants a er randomisation, withdrawal of participants from a study, or loss to follow-up. The exclusion of these data from analysis may break the randomisation and potentially introduces bias. Where there were missing data and where relevant we contacted study authors to pose specific queries about these data. In the absence of other information, for pressure ulcer incidence we assumed that participants with missing data did not develop new pressure ulcers for the main analysis (i.e. we added missing data to the denominator but not the numerator). We examined the impact of this assumption through undertaking a sensitivity analysis (see Sensitivity analysis). We supplemented this assessment of clinical and methodological heterogeneity with information regarding statistical heterogeneity, assessed using the Chi 2 test. We considered a P value less than 0.10 to indicate statistically significant heterogeneity given that the Chi 2 test has low power, particularly in the case where studies included in a meta-analysis have small sample size. We carried out this statistical assessment in conjunction with the I 2 statistic (Higgins 2003) , and the use of prediction intervals for random-e ects metaanalyses (Borenstein 2017; Riley 2011). The I 2 statistic is the percentage of total variation across studies due to heterogeneity rather than chance (Higgins 2003). Very broadly, we considered that I 2 values of 25% or less may indicate a low level of heterogeneity and values of 75% or more may indicate very high heterogeneity (Higgins 2003) . For random-e ects models, where the meta-analysis had more than 10 included studies and no clear funnel plot asymmetry, we also planned to present 95% prediction intervals (Deeks 2019). We planned to calculate prediction intervals following methods proposed by Borenstein 2017. Random-e ects analyses produce an average treatment e ect, with 95% confidence intervals indicating where the true population average value is likely to lie. Prediction intervals quantify variation away from this average due to between-study heterogeneity. The interval conveys where a future study treatment e ect estimate is likely to fall based on the data analysed to date (Riley 2011). Prediction intervals are always wider than confidence intervals (Riley 2011). It is important to note that prediction intervals will reflect heterogeneity of any source, including from methodological issues as well as clinical variation. For this reason, some authors have suggested that prediction intervals are best calculated for studies at low risk of bias, to ensure intervals that have meaningful clinical interpretation (Riley 2011). We had planned to calculate prediction intervals for all studies to assess heterogeneity and then to explore the impact of risk of bias in subgroup analysis as detailed below. However, we did not calculate any prediction intervals because all conducted meta-analyses contained fewer than 10 studies. We followed the systematic framework recommended by Page 2019 to assess risk of bias due to missing results (non-reporting bias) in the meta-analysis of pressure ulcer incidence data. To make an overall judgement about risk of bias due to missing results, we: • identified whether pressure ulcer incidence data were unavailable by comparing the details of outcomes in trials registers, protocols or statistical analysis plans, if available, with reported results. If the above information sources were unavailable, we compared outcomes in the conference abstracts or in the methods section of the publication, or both, with the reported results. If we found non-reporting of study results, we then judged whether the non-reporting was associated with the nature of findings by using the 'Outcome Reporting Bias In Trials' (ORBIT) system (Kirkham 2018); • assessed the influence of definitely missing pressure ulcer incidence data on meta-analysis; and • assessed the likelihood of bias where a study had been conducted but not reported in any form. For this assessment, we considered whether the literature search was comprehensive and planned to produce a funnel plot for meta-analysis for seeking more evidence about the extent of missing results, provided there were at least 10 included studies (Peters 2008; Salanti 2014). However, we did not produce a funnel plot for any meta-analysis because all analyses in this review had fewer than 10 included studies. We summarised the included studies narratively and synthesised data using meta-analysis where applicable. We structured comparisons according to type of comparator and then by outcomes ordered by follow-up period. We considered clinical and methodological heterogeneity and undertook pooling when studies appeared appropriately similar in terms of participants, support surfaces and outcome type. Where statistical synthesis of data from more than one study was not possible or considered inappropriate, we conducted a narrative review of eligible studies. Once the decision to pool was made, we used a random-e ects model, which estimated an underlying average treatment e ect from studies. Conducting meta-analysis with a fixed-e ect model in the presence of even minor heterogeneity may provide overly narrow confidence intervals. We used the Chi 2 test and I 2 statistic to quantify heterogeneity but not to guide choice of model for meta-analysis (Borenstein 2009). We exercised caution when metaanalysed data were at risk of small study e ects because use of a random-e ects model may be unsuitable here. In this case, or where there were other reasons to question the choice of a fixed-e ect or random-e ects model, we assessed the impact of the approach using sensitivity analyses to compare results from alternate models (Thompson 1999). We performed meta-analyses largely using Review Manager 5.4 (Review Manager 2020). We presented data using forest plots where possible. For dichotomous outcomes, we presented the summary estimate as an RR with 95% CI. Where continuous outcomes were measured, we presented an MD with 95% CI. We planned to report SMD estimates where studies measured the same outcome using di erent methods. For time-to-event data, we presented the summary estimates as HRs and 95% CIs. Trusted evidence. Informed decisions. Better health. When important heterogeneity occurred, we planned to follow these steps, proposed by Cipriani 2013, to investigate further: • check the data extraction and data entry for errors and possible outlying studies; • if outliers existed, perform sensitivity analysis by removing them; and • if heterogeneity was still present, we planned to perform subgroup analyses for study-level characteristics (see below) in order to explain heterogeneity as far as possible. However, we did not undertake any subgroup analysis because metaanalyses in this review included fewer than 10 studies. We investigated heterogeneity using the methods described in the Cochrane Handbook for Systematic Reviews of Interventions (Deeks 2019). We planned to perform subgroup analyses for binary and categorical factors (or meta-regression for continuous factors) to determine whether the size of treatment e ects was influenced by these four study-level characteristics: • risk of bias (binary: low or unclear risk of bias; and high risk of bias; Schulz 1995); • settings (categorical: acute care and other hospital settings; long-term care settings; operating theatre setting; and intensive care unit); • baseline skin status (categorical: participants at risk, mixed skin status or non-reporting; non-blanchable erythema; existing ulcers of Stage 2 or serious; Shi 2018c); and • follow-up duration (continuous). We did not perform subgroup analysis/meta-regression when the number of studies included in the meta-analysis was not reasonable (i.e. fewer than 10). We planned to compare subgroup findings using the 'Test for Subgroup Di erences' in Review Manager 5.4 (Review Manager 2020). We assessed the robustness of meta-analysis of pressure ulcer incidence data through doing sensitivity analyses as follows. • Impact of considering specific alternating pressure (active) air surfaces as di erent surfaces rather than as a general group. We undertook a sensitivity analysis to examine whether disentangling specific alternating pressure (active) air surfaces that were listed in Types of interventions from alternating pressure (active) air surface as a single intervention a ected the meta-analysis results. • Impact of the selection of pressure ulcer incidence outcome measure. The proportion of participants developing a new pressure ulcer was the primary outcome measure for this review but we also analysed time to pressure ulcer development, where data were available. • Impact of missing data. The primary analysis assumed that participants with missing data did not develop new pressure ulcers. We also analysed pressure ulcer incidence by only including data for the participants for whom we had endpoint data (complete cases). We noted that when a study only had complete case data (i.e. missing data or the numbers of participants randomised were not reported), complete case data were considered in the related main analysis (Di erences between protocol and review). • Impact of altering the e ects model used. We used a randome ects model for the main analysis, followed by a fixed-e ect analysis. We presented the main, pooled results of the review in 'Summary of findings' tables. These tables present key information concerning the certainty of evidence, the magnitude of the e ects of the interventions examined and the sum of available data for the main outcomes (Schünemann 2019). These tables also include an overall grading of the certainty of the evidence associated with each of the main outcomes that we assessed using the GRADE approach via GRADEpro GDT so ware. The GRADE approach defines the certainty of a body of evidence as the extent to which one can be confident that an estimate of e ect or association is close to the true quantity of specific interest. The GRADE assessment involves consideration of five factors: within-trial risk of bias, directness of evidence, heterogeneity, precision of e ect estimates, and risk of publication bias (Schünemann 2019). The certainty of evidence can be assessed as being: high, moderate, low or very low. RCT evidence has the potential to be high certainty. We did not downgrade the certainty of evidence for the risk of bias factor in a specific circumstance. That is if the blinding of participants and personnel was the only domain resulting in our judgement of overall high risk of bias for the included studies; however for these studies it was impossible to blind participants and personnel. When downgrading for imprecision, we followed the methods described in Guyatt 2011: either considering both the optimal information size (OIS) and the 95% CI of each meta-analysis if they were estimable; or considering the sample size, the number of events and other e ectiveness indicators if the calculation of OIS and undertaking a meta-analysis were not applicable. Where necessary, we used the GRADE 'default' minimum important di erence values (RR = 1.25 and 0.75) as the thresholds to judge if a 95% CI was wide (imprecise) so as to include the possibility of clinically important harm and benefit (Guyatt 2011). We presented a separate 'Summary of findings' table for all but one comparison evaluated in this review. The exception was the comparison of alternating pressure (active) air surfaces versus another type of alternating pressure (active) air surfaces; see Di erences between protocol and review. We presented these outcomes in the 'Summary of findings' tables: • proportion of participants developing a new pressure ulcer; • time to pressure ulcer development; • support-surface-associated patient comfort; • all reported adverse events; • health-related quality of life; and • cost-e ectiveness. Trusted evidence. Informed decisions. Better health. We prioritised the time points and method of outcome measurement specified in Types of outcome measures for presentation in 'Summary of findings' tables'. Where we did not pool data for some outcomes within a comparison, we conducted a GRADE assessment for each of these outcomes and presented these assessments in a narrative format in 'Summary of findings' tables (Di erences between protocol and review). See Characteristics of included studies; Characteristics of excluded studies; Characteristics of studies awaiting classification; and Characteristics of ongoing studies. The electronic searches identified 1624 records, including 1164 from electronic databases and 460 from trial registries. We excluded 218 duplicate records and screened 1406 records, of which 233 were identified as potentially eligible and obtained as full-text. Following full-text screening, we considered 54 records of 31 studies eligible for inclusion in this review (Andersen 1982; Aronovitch 1999; Ballard 1997; Beeckman 2019; Bliss 1967; Bliss 1995; Cavicchioli 2007; Conine 1990; Daechsel 1985; Demarre 2012; Finnegan 2008; Gray 2008; Grindley 1996; Hampton 1997; Jiang 2014; Laurent 1998; Malbrain 2010; Nixon 2006; Nixon 2019; Phillips 1999; Price 1999; Pring 1998; Rosenthal 2003; Russell 2000; Sanada 2003; Sauvage 2017; Sideranko 1992; Stapleton 1986; Taylor 1999; Theaker 2005; Whitney 1984 Cochrane Database of Systematic Reviews Included studies Of the 32 included RCTs, 26 had a parallel group design: four studies with three arms and 22 with two arms. Six studies had particular design features: • two studies applied cross-over design (Ballard 1997; Grindley 1996) ; • one study had a 2 × 2 factorial design (Laurent 1998), containing the comparison of alternating pressure (active) air surfaces versus standard hospital surfaces in an intensive care unit (ICU); • one study appeared to be a multi-arm, multi-stage trial design with eight arms, of which seven were randomised and eligible for this review (Bliss 1995); • two studies used a series of n-of-1 trial design (i.e. a randomised controlled crossover trial in a single participant) (Phillips 1999; Pring 1998 Of the 30 studies that clearly stated duration of follow-up, the median was 14 days (range: 3 to 180 days). Of the 32 studies, 31 enrolled a total of 9058 participants (median study sample size: 83 participants, or the number of individual trials comprising a series of n-of-1 trials; range: 10 to 2029) whilst one (Hampton 1997) did not specify the number of participants. The average participant age was specified for 29 studies and ranged between 37.2 and 87.0 years (median: 69.1 years). The sex of the participants was specified for 26 studies; within these, 3654 (44.4%) of participants were male and 4571 (55.6%) were female. Of the 32 studies, 27 (8620 participants) recruited people at risk of having a new ulcer with risk assessed largely using the Waterlow, Norton or Braden scales. In 18 of these studies, 3812 (44.2%) participants were free of pressure ulcers at baseline; in nine studies, 4808 (55.8%) participants with superficial ulcers were enrolled (Bliss 1967; Bliss 1995; Cavicchioli 2007; Grindley 1996; Malbrain 2010; Nixon 2006; Nixon 2019; Ra er 2011; Whitney 1984) . Two studies did not specify the skin status at baseline (Hampton 1997; Laurent 1998) ; one study stated that their participants had no risk of developing a pressure ulcer (Ballard 1997); and two studies recruited people with severe full-thickness pressure ulcers alone (Finnegan 2008; Rosenthal 2003) . Participants were from a variety of settings, including: • a mixture of secondary and community in-patient facilities (Nixon 2019), • acute care settings (including accident and emergency departments, and hospitals in general) (Andersen 1982; Aronovitch 1999; Bliss 1967; Bliss 1995; Cavicchioli 2007; Demarre 2012; Finnegan 2008; Gray 2008; Hampton 1997; Jiang 2014; Laurent 1998; Nixon 2006; Price 1999; Ra er 2011; Russell 2000; Sanada 2003; Stapleton 1986; Taylor 1999; Whitney 1984) , • intensive care units (Malbrain 2010; Sideranko 1992; Theaker 2005) , and • community and long-term care settings (including hospice, community, nursing homes, extended care facilities, rehabilitation wards, long-term facilities and geriatric units) (Ballard 1997; Beeckman 2019; Conine 1990; Daechsel 1985; Grindley 1996; Phillips 1999; Pring 1998; Rosenthal 2003; Sauvage 2017) . The studies investigated a wide range of alternating pressure (active) air surfaces with alternating pressure cycle periods ranging from 7.5 to 30 minutes. Of these studies, Sanada 2003 included two types of alternating pressure (active) air surfaces. Hybrid systems with alternating pressure (active) and continuously static (reactive) capabilities were used in five studies (Gray 2008; Hampton 1997; Ra er 2011; Taylor 1999; Theaker 2005 Cochrane Database of Systematic Reviews (active) air surfaces with low air loss features were used in two studies (Rosenthal 2003; Theaker 2005) . Three studies (Andersen 1982; Conine 1990; Daechsel 1985) did not specify the type (or cycle time) of the alternating pressure (active) air surfaces they used. Full details of alternating pressure (active) air surfaces and comparators are listed in Appendix 4 and in results below. Four studies used comparator group surfaces defined by study authors as 'standard hospital surfaces' that could not be classified further using the NPIAP S3I support surface terms and definitions (Andersen 1982; Bliss 1967; Laurent 1998; Sanada 2003) . Of these four studies, Sanada 2003 reported use of a 'standard hospital surface' made of polyester (Paracare®) whilst the remaining three studies did not specify the type of surface they referred to as standard hospital surfaces. Twelve studies specified co-interventions they applied (e.g. repositioning, cushions) (Beeckman 2019; Bliss 1967; Conine 1990; Daechsel 1985; Finnegan 2008; Gray 2008; Jiang 2014; Malbrain 2010; Price 1999; Rosenthal 2003; Sanada 2003; Whitney 1984) . All twelve stated or indicated that the same co-interventions were applied in all study groups. Of the 32 included studies, 18 specified the details of funding sources. Eleven studies were completely or partly funded by industry or received mattresses under evaluation from industries (Aronovitch 1999; Ballard 1997; Beeckman 2019; Bliss 1995; Daechsel 1985; Finnegan 2008; Grindley 1996; Price 1999; Ra er 2011; Russell 2000; Theaker 2005) , and seven studies were supported by public funding (Bliss 1967; Conine 1990; Demarre 2012; Jiang 2014; Nixon 2006; Nixon 2019; Stapleton 1986) . We excluded 140 studies (with 165 records). The main reasons for these 140 exclusions were: irrelevant and ineligible interventions (53 studies); ineligible study design (e.g. non-RCT, reviews, commentary articles; 52 studies); studies focused on the treatment rather than prevention of pressure ulcers (20 studies); incorrect randomisation and non-randomised methods (eight studies); studies with ineligible outcomes (four studies); clinical trials that were withdrawn (two studies; NCT02634892; NCT02735135); and ineligible participants (healthy subjects; one study). We also identified eight duplicates in screening full texts (see Figure 1 ). We did not identify any ongoing studies. There were six studies (six records) about which we could not make eligibility decisions. We were unable to determine whether Gardner 2008 measured one or more outcomes relevant to this review. We could not obtain the full-text of five studies (in part due to more limited access to intra-library loans during the COVID-19 period) despite extensive e orts made (Chaloner 2000; Henn 2004; Knight 1999; Mastrangelo 2010b; Melland 1998 We judged seven of the 32 studies as having an unclear overall risk of bias for the primary outcome (Gray 2008; Grindley 1996; Jiang 2014; Malbrain 2010; Rosenthal 2003; Sideranko 1992; Taylor 1999) . We judged all the remaining 25 studies as having findings at a high overall risk of bias, of which two had an unclear risk of bias judgements for all domains (Hampton 1997; Stapleton 1986 ) and 23 had one or more domains with a high risk of bias judgement (Andersen 1982; Aronovitch 1999; Ballard 1997; Beeckman 2019; Bliss 1967; Bliss 1995; Cavicchioli 2007; Conine 1990; Daechsel 1985; Demarre 2012; Finnegan 2008; Laurent 1998; Nixon 2006; Nixon 2019; Phillips 1999; Price 1999; Pring 1998; Ra er 2011; Russell 2000; Sanada 2003; Sauvage 2017; Theaker 2005; Whitney 1984) . Of these 23 studies, 15 had a high risk of bias judgement for the primary outcome in domains of blinding of participants and personnel, blinding of outcome assessment, or both (Andersen 1982; Beeckman 2019; Daechsel 1985; Demarre 2012; Finnegan 2008; Laurent 1998; Nixon 2006; Nixon 2019; Price 1999; Pring 1998; Ra er 2011; Russell 2000; Sauvage 2017; Theaker 2005; Whitney 1984) . We ran a comprehensive search and were able to locate one eligible study, Ra er 2011, from other resources and one conference abstract, Laurent 1998. We considered the risk of having missed published reports to be low. We were unable to assess for the risk of non-publication of studies with negative findings as we could not present funnel plots given the small number of included studies in each analysis. See: Summary of findings 1 Alternating pressure (active) air surfaces compared with foam surfaces for pressure ulcer prevention; Summary of findings 2 Alternating pressure (active) air surfaces compared with reactive air surfaces for pressure ulcer prevention; Summary of findings 3 Alternating pressure (active) air surfaces compared with reactive water-filled surfaces for pressure ulcer prevention; Summary of findings 4 Alternating pressure (active) air surfaces compared with reactive fibre surfaces for pressure ulcer prevention; Summary of findings 5 Alternating pressure (active) air surfaces on operating tables and subsequently on ward beds compared with reactive gel surfaces on operating tables followed by foam surfaces on ward beds for pressure ulcer prevention See Summary of findings 1; Summary of findings 2; Summary of findings 3; Summary of findings 4; Summary of findings 5. Unless otherwise stated, random-e ects analysis was used throughout. Each pooled result presented is an average e ect, rather than a common e ect and should be interpreted as such. Trusted evidence. Informed decisions. Better health. We have not reported data from the four studies with comparator group surfaces that we could not classify in the main body of the results (Andersen 1982; Bliss 1967; Laurent 1998; Sanada 2003) . For completeness, we summarise the results of these studies in Appendix 5. We performed data analyses for the following comparisons and outcomes. Where applicable, we performed pre-specified sensitivity analyses as noted in Sensitivity analysis. Comparison 1: Alternating pressure (active) air surfaces versus foam surfaces (six studies, 2427 participants) One study, Bliss 1995, randomised participants to three types of foam mattresses (in three individual trial arms) which we combined into a single study arm for analysis against the relevant comparison, which was a type of alternating pressure (active) air surface. However, this study and Whitney 1984 (in total 180 participants) reported no outcomes directly relevant to this review and so none of their data were analysable. Rosenthal 2003 evaluated an alternating pressure (active) air surface with a low-air-loss feature. The remaining studies compared a standard alternating pressure (active) air surface with a foam surface comparison. Proportion of participants developing a new pressure ulcer (median follow-up duration 90 days, minimum 30 days, maximum 6 months or unspecified) Four studies (2247 participants) reported data for this outcome and the data from these studies were pooled (Nixon 2019; Rosenthal 2003; Sauvage 2017; Stapleton 1986) . Alternating pressure (active) air surfaces (83/1125 (7.4%)) may reduce the proportion of participants developing pressure ulcers compared with foam surfaces (117/1122 (10.4%)); however, this is lowcertainty evidence. The RR was 0.63 (95% CI 0.34 to 1.17; I 2 = 63%; Analysis 1.1). Evidence certainty was downgraded once for risk of bias (two studies contributing 50% weight in the metaanalysis had either one domain other than performance bias at high risk of bias, or all domains at unclear risk of bias; two studies contributing 50% of weight in the meta-analysis had domains other than performance bias at low or unclear risk of bias), and once for imprecision as, despite the fact that the optimal information size (OIS) was met, the wide confidence interval crossed RR = 0.75. We considered the studies included in Analysis 1.1 heterogeneous in terms of all pre-specified subgroup factors (overall 'risk of bias', care settings, skin status at baseline, and follow-up) and there was some indication of statistical heterogeneity (Chi 2 test P value = 0.07; Tau 2 = 0.18; I 2 = 63%). We noticed that, of the four studies, Sauvage 2017 reported a greater treatment e ect than the other three. Once the extreme value was removed (Sauvage 2017), I 2 went from 63% to 0%, but the overall estimate remained consistent with the main analysis (RR 0.79, 95% CI 0.60 to 1.03; Chi 2 test P value = 0.83; Tau 2 = 0.00; I 2 = 0%). Of the four studies, Sauvage 2017 di ered from the others in terms of care settings: Sauvage 2017 was conducted at long-term care settings whilst the others were at acute care settings. However, as noted in Subgroup analysis and investigation of heterogeneity, because there were fewer than 10 studies, we did not undertake a subgroup analysis. We performed sensitivity analyses for the following factors but did not use complete case data for a sensitivity analysis because the four included studies did not report missing data. • Sensitivity analysis deconstructing di erent types of alternating pressure (active) air surfaces into single groups . Splitting the class of alternating pressure (active) air surfaces resulted in two independent analyses: (1) alternating pressure (active) air surfaces compared with foam surfaces (Nixon 2019; Sauvage 2017; Stapleton 1986); and (2) alternating pressure (active) low-air-loss surfaces compared with foam surfaces (Rosenthal 2003) . There were insu icient data to show whether results were consistent across these subgroups. • Sensitivity analysis with fixed-e ect (rather than randome ects) model . Sauvage 2017), and the data from these were pooled. Analysis 1.2 resulted in a HR of 0.41 (95% CI 0.10 to 1.64; I 2 = 86%) which was consistent with the main analysis. It is uncertain whether there is a di erence in the risk of developing a new pressure ulcer, over 60 days' follow-up, between alternating pressure (active) air surfaces and foam surfaces. Evidence is of very low certainty, downgraded once for high risk of bias in one study with 40% of analysis weight, twice for substantial inconsistency, and once for imprecision. Only Sauvage 2017 (76 participants) reported this outcome, defined by the study authors as the perception of patient comfort and measured using a satisfaction questionnaire. Sauvage 2017 reported no significant di erence in the overall satisfaction between study groups (P = 0.21); no other information was reported. We are uncertain whether there is any di erence between alternating pressure (active) air surfaces and foam surfaces in patient comfort responses. Evidence is of very low certainty, downgraded twice for high risk of detection bias, and once for imprecision. events between alternating pressure (active) air surfaces and foam surfaces. Evidence is of very low certainty, downgraded once for unclear risk of bias in two studies with about half weight, and twice for inconsistency. Only Nixon 2019 (2029 participants) reported health-related quality of life, measured using the EQ-5D-5L (with 267 participants only) and PU-QoL-UI (with 233 participants only). It is unclear if there is a di erence in health-related quality of life (measured using either the EQ-5D-5L or PU-QoL-UI) at 90 days follow-up between alternating pressure (active) air surfaces and foam surfaces (lowcertainty evidence). Nixon 2019 reported a MD in the 90-day EQ-5D-5L of 0.00 (95% CI -0.05 to 0.05) between 118 participants using alternating pressure (active) air surfaces and 149 using foam surfaces; and a MD in 90-day PU-QoL-UI of 0.00 (95% CI -0.03 to 0.03) between 107 participants using alternating pressure (active) air surfaces and 126 using foam surfaces (Analysis 1.3). Evidence certainty was downgraded twice for imprecision due to small sample sizes for this outcome. Only Nixon 2019 (2029 participants) reported the incremental cost per quality-adjusted life-years (QALYs) gained based on within-trial analyses. Moderate-certainty evidence suggests that alternating pressure (active) air surfaces have a 99% probability of being coste ective at a threshold of GBP 20,000 compared with reactive foam surfaces. Evidence certainty was downgraded once for imprecision for the EQ-5D-5L outcome from which QALY scores were calculated. Sideranko 1992) and the data from these were pooled. It is uncertain whether there is a di erence in the proportion of participants developing a new ulcer between alternating pressure (active) air surfaces (32/799 (4.0%)) and reactive air surfaces (19/849 (2.2%)). The RR was 1.61 (95% CI 0.90 to 2.88; I 2 = 3%; Analysis 2.1). Evidence is of very low certainty, downgraded twice for high risk of bias in domains other than performance bias for three studies contributing over 54% weight in the meta-analysis, and once for imprecision as, despite the fact that the OIS was met, the wide confidence interval crossed RR = 1.25. We considered the studies in Analysis 2.1 heterogeneous in terms of care settings, skin status at baseline, and overall 'risk of bias'. However, we did not perform any pre-specified subgroup analysis because, as noted in Subgroup analysis and investigation of heterogeneity, the number of included studies was fewer than 10, meaning it would be di icult to meaningfully interpret the results. • Sensitivity analysis with complete case data . This resulted in a RR of 1.62 (95% CI 0.90 to 2.89; I 2 = 3%). The evidence was consistent with the main analysis Analysis 2.1. • Sensitivity analysis with fixed-e ect (rather than randome ects) model . The use of a fixed-e ect model resulted in a RR of 1.72 (95% CI 1.00 to 2.97; I 2 = 3%) so this was consistent with the main analysis. • Sensitivity analysis with time to pressure ulcer development as pressure ulcer incidence measure (follow-up duration of 14 days). Only Beeckman 2019 (308 participants) reported this outcome. Low-certainty evidence suggests that people treated with alternating pressure (active) air surfaces may be at more risk of developing an incident pressure ulcer over 14 days' follow-up than those treated with reactive air surfaces in a nursing home setting (HR 2.25; 95% CI 1.05 to 4.83; Analysis 2.2). The results are sensitive to the choice of format for the primary outcome measure so the main analysis results should be interpreted cautiously. Evidence certainty is low, downgraded twice for high risk of detection bias. Support-surface-associated patient comfort (median follow-up duration 11 days, minimum 5 days, maximum 14 days) Four studies (1364 participants) reported this outcome (Cavicchioli 2007; Finnegan 2008; Jiang 2014; Price 1999) . The four studies report a range of di erent measures for this outcome and they cannot be pooled (see Table 2 ). We are uncertain about any di erence in patient comfort responses between alternating pressure (active) air surfaces and reactive air surfaces. Evidence is of very low certainty, downgraded once for high overall risk of bias in three small studies but unclear risk of bias in one large study, and twice for substantial inconsistency. Not reported. Not reported. Not reported. Three studies compared alternating pressure (active) air surfaces with reactive water surfaces (Andersen 1982; Bliss 1995; Sideranko 1992) . Of these, Bliss 1995 (56 participants) reported the outcome of the numbers of treatment sessions in which pressure ulcers developed or worsened, which we considered not directly relevant to this review. Trusted evidence. Informed decisions. Better health. Cochrane Database of Systematic Reviews pressure ulcer between alternating pressure (active) air surfaces (12/186 (6.5%)) compared with reactive water surfaces (9/172 (5.2%)). The RR was 1.21 (95% CI 0.52 to 2.83; I 2 = 0%; Analysis 3.1). Evidence is of very low certainty, downgraded twice for high risk of detection bias in one study contributing over 60% weight in the meta-analysis and unclear overall risk of bias in another study, and twice for substantial imprecision as the OIS was not met and the confidence interval was very wide and crossed RRs = 0.75 and 1.25. The included studies did not report data on time to pressure ulcer incidence. We considered studies heterogeneous in terms of care setting, and overall 'risk of bias'. However, we did not perform any prespecified subgroup analysis because, as noted in Subgroup analysis and investigation of heterogeneity, the number of included studies was fewer than 10, meaning it would be di icult to meaningfully interpret the results. • Sensitivity analysis with fixed-e ect (rather than randome ects) model . The use of a fixed-e ect model resulted in a RR of 1.21 (95% CI 0.53 to 2.78; I 2 = 0%). The evidence remained consistent with the main analysis Analysis 3.1 (Appendix 6). None reported. Four studies made this comparison (Bliss 1995; Conine 1990; Daechsel 1985; Stapleton 1986) . Of these, Bliss 1995 randomised participants into two types of fibre-filled surfaces (in two individual study arms) that we combined into a single study arm. Bliss 1995 reported the outcome of the numbers of treatment sessions in which pressure ulcers developed or worsened, which we considered not directly relevant to this review. Proportion of participants developing a new pressure ulcer (minimum follow-up duration 17.7 days, maximum three months or unspecified) All four studies (384 participants) reported this outcome (Bliss 1995; Conine 1990; Daechsel 1985; Stapleton 1986) . We pooled the data from three studies (285 participants). It is uncertain whether there is a di erence in the proportion of participants developing a new pressure ulcer between alternating pressure (active) air surfaces (54/141 (38.3%)) and reactive fibre surfaces (61/144 (42.4%)). The RR was 0.90 (95% CI 0.68 to 1.19; I 2 = 0%; Analysis 4.1). Evidence is of very low certainty, downgraded twice for high risk of bias in domains other than performance bias in two studies contributing over 80% weight to the meta-analysis, and once for imprecision as the OIS was not met. The included studies did not report data on time to pressure ulcer incidence. We considered these studies heterogeneous in terms of care settings, participants' average age and skin status at baseline. However, we did not perform any pre-specified subgroup analysis because, as noted in Subgroup analysis and investigation of heterogeneity, the number of included studies was fewer than 10, meaning it would be di icult to meaningfully interpret the results. • Sensitivity analysis using complete case data . This resulted in a RR of 0.93 (95% CI 0.72 to 1.20; I 2 = 0%). The evidence is consistent with the main analysis Analysis 4.1 (Appendix 6). • Sensitivity analysis with fixed-e ect (rather than randome ects) model . The use of a fixed-e ect model resulted in a RR of 0.90 (95% CI 0.68 to 1.20; I 2 = 0%) and this remained consistent with the main analysis Analysis 4.1 (Appendix 6). Only Conine 1990 (187 participants) reported this outcome. We are uncertain about any di erence between alternating pressure (active) air surfaces and reactive fibre surfaces in patient comfort responses. Conine 1990 reported 19 dropouts among 93 people using alternating pressure (active) air surfaces; and 17 of 94 using reactive fibre surfaces. The reason for dropout was given as discomfort. Evidence is of very low certainty, downgraded once for high overall risk of bias for this outcome, once for indirectness, and once for imprecision. Not reported. Not reported. Not reported. Comparison 5: Alternating pressure (active) air surfaces on operating tables and subsequently on postoperative ward beds versus reactive gel surfaces used on operating tables followed by foam surfaces on postoperative ward beds (two studies, 415 participants) Two studies (415 participants) were included in this comparison (Aronovitch 1999; Russell 2000) . Both studies (415 participants) reported this outcome and these data were pooled (Aronovitch 1999; Russell 2000) . Alternating pressure (active) air surfaces applied on both operating tables and hospital beds (3/210 (1.4%)) may reduce the proportion of people developing a new pressure ulcer compared with reactive gel surfaces used on operating tables followed by foam surfaces applied on hospital beds (14/205 (6.8%)); however, this is lowcertainty evidence. The RR is 0.22 (95% CI 0.06 to 0.76; I 2 = Library Trusted evidence. Informed decisions. Better health. Cochrane Database of Systematic Reviews 0%; Analysis 5.1). Evidence certainty was downgraded once for risk of bias (one study contributing 36% of weight to the metaanalysis was at high risk of attrition bias whilst the other study was at unclear risk of bias for more than one domain other than performance bias) and once for imprecision as, despite the fact that the OIS was met, the 95% CI crossed RR = 0.75. The included studies did not report data on time to pressure ulcer incidence. We considered both studies similar in terms of care settings, followup duration, overall risk of bias, participant characteristics and interventions: statistical heterogeneity was low (Chi 2 test P value = 0.55; Tau 2 = 0.00; I 2 = 0%). Because the number of included studies was less than 10, we did not undertake a subgroup analysis. • Sensitivity analysis with fixed-e ect (rather than randome ects) model . The use of a fixed-e ect model resulted in a RR of 0.21 (95% CI 0.06 to 0.72; I 2 = 0%) and this remained consistent with the main analysis Analysis 5.1 (Appendix 6). None reported. Only Russell 2000 (198 participants) reported this outcome. It is uncertain if there is a di erence between alternating pressure (active) air surfaces and the alternative in adverse events. The study authors claimed that approximately one half of people in each group reported one or more types of adverse events, with no di erence between groups reported. The study authors also noted that no adverse events were considered to be related to the mattresses assigned. Evidence is of very low certainty, downgraded once for unclear risk of bias in more than one domain other than performance bias, and twice for imprecision due to small sample size. Not reported. Not reported. We included 10 studies (2868 participants) that compared two or more di erent types of alternating pressure (active) air surfaces (Ballard 1997; Demarre 2012; Gray 2008; Grindley 1996; Hampton 1997; Nixon 2006; Pring 1998; Ra er 2011; Taylor 1999; Theaker 2005) . Specifically, three studies included an alternating pressure (active) air surface with a hybrid (active/reactive) function (Gray 2008; Hampton 1997; Taylor 1999) ; Ra er 2011 and Theaker 2005 compared two types of alternating pressure (active) air surface that could both be classed as hybrid air surfaces, and one type of hybrid air surface used in Theaker 2005 also had a low-air-loss feature. The remaining five studies compared di erent types of standard alternating pressure (active) air surfaces. We did not pool data from the 10 studies as such comparisons are not meaningful beyond the individual study level. We summarise study findings narratively below with key outcome data presented in Table 2 and Table 3 . Proportion of participants developing a new pressure ulcer (median follow-up period one month, minimum 10.5 days, maximum six months) Seven studies (2833 participants) reported this outcome with no study showing a di erence in the proportion of people with incident pressure ulcers between di erent types of alternating pressure (active) air surfaces (Demarre 2012; Gray 2008; Hampton 1997; Nixon 2006; Ra er 2011; Taylor 1999; Theaker 2005) . See Table 3 . These study findings were considered to be of low certainty overall, downgraded once for risk of bias as two small studies were at high risk of bias in domains other than performance bias and all the remaining five studies were at unclear risk of bias in at least one domain other than performance bias, and once for imprecision as the number of events was relatively low and the 95% CIs in each study included both benefits and harms as well as no e ect. Two studies (2581 participants) reported time to pressure ulcer development (Demarre 2012; Nixon 2006; follow-up period 14 and 60 days). Neither of these studies suggested a di erence in the risk of developing an incident pressure ulcer over 60 days' followup between these support surfaces. This is consistent with the pressure ulcer risk finding. Evidence is of low certainty, downgraded once for unclear risk of bias in domains other than performance bias in both included studies, and once for imprecision as the 95% CIs of both studies included both benefits and harms as well as no e ect. Support-surface-associated patient comfort (median follow-up duration 10.5 days, minimum 3 days, maximum 60 days) Seven studies (2705 participants) reported this outcome (Ballard 1997; Demarre 2012; Grindley 1996; Nixon 2006; Pring 1998; Ra er 2011; Taylor 1999) . The studies reported a range of di erent measures and outcome data cannot be easily interpreted (see Table 2 ). We are uncertain if there is a di erence in support-surfaceassociated patient comfort between di erent types of alternating pressure (active) air surfaces. Evidence is of very low certainty, downgraded once for risk of bias (three small studies with a high risk of bias judgement for at least one domain other than performance bias, and all the rest having an unclear judgement for at least one domain other than performance bias), once for inconsistency in terms of comfort results across studies, and once for strongly suspected publication bias. Only Nixon 2006 (1971 participants) reported this outcome for its comparison of mattress and overlay formats of alternating air (active) surfaces. We are uncertain if there is a di erence in the adverse events between the two formats of alternating pressure (active) air surfaces. Nixon 2006 reported that 377 adverse events were observed among 308 participants within 60 days. However, the study authors did not report these data by study groups, although they did present surface-related adverse events by study groups (10 participants in alternating pressure air mattresses and four in alternating pressure air overlays). Evidence is of very low Cochrane Database of Systematic Reviews certainty, downgraded twice for high overall risk of bias for this outcome due to high attrition bias, and twice for imprecision due to small sample size. Not reported. Cost-e ectiveness (follow-up duration median 60 days) Only Nixon 2006 (1971 participants) reported this outcome using a trial-based, cost-e ectiveness analysis for its comparison of mattress and overlay formats of alternating air (active) surfaces. The cost-e ectiveness acceptability curve indicated that, on average, alternating pressure mattresses were associated with an 80% probability of being cost-saving compared with alternating pressure overlays. Evidence is of moderate certainty, downgraded once for an unclear risk of bias in one domain other than performance bias: Nixon 2006 was at an unclear risk of detection bias in terms of both the health benefit (time to pressure ulcer development) and costs in the economic analysis. In its base case analysis, Nixon 2006 reported that alternating pressure air mattresses were associated with a delay in pressure ulcer development and lower overall costs (mean di erence in total costs between overlay and mattress groups: GBP 283.60 per participant on average, 95% CI GBP 377.59 to GBP 976.79; and the mean di erence in the restricted Kaplan-Meier estimates of time to pressure ulcer onset between overlay and mattress groups: -10.63 days, 95% bias-corrected CI of the di erence -24.40 to 3.09 days). The analysis was from the perspective of the UK National Health Service (NHS) and Personal Social Service; but there was no cost discounting due to the time horizon being less than one year. We report evidence from 32 RCTs on the e ects of alternating pressure (active) air beds or mattresses compared with any support surface on the incidence of pressure ulcers in any setting and population. We did not analyse data reported in four studies that compared alternating pressure (active) air surfaces with 'standard hospital surfaces' that were not well described, because the term 'standard hospital surface' does not represent a single recognisable surface internationally or over time. We summarise key findings for six specific comparisons that had data analyses as follows: • Alternating pressure air surfaces versus foam surfaces: alternating pressure (active) air surfaces may reduce the proportion of people developing incident pressure ulcers compared with foam surfaces (4 studies, 2247 participants; low-certainty evidence). It is uncertain whether there is any di erence in the risk of developing a new pressure ulcer over 60 days' follow-up (2 studies, 2105 participants; very low-certainty evidence); in support-surface-associated patient comfort (1 study, 76 participants; very low-certainty evidence); in health-related quality of life at 90 days' follow-up (1 study, 2029 participants; low-certainty evidence); as well as in the number of all reported adverse events (3 studies, 2181 participants; very low-certainty evidence) between these types of support surfaces. We found moderate-certainty coste ectiveness evidence that alternating pressure (active) air surfaces are probably more cost-e ective than foam surfaces. Although there were negligible di erences in participantreported health utility in those allocated to alternating pressure (active) air surfaces and foam surfaces, the di erence in costs between these trial arms (with the arm of foam surfaces having higher costs) meant the cost-e ectiveness finding favoured the alternating pressure (active) air surfaces (Nixon 2019). • Alternating pressure air surfaces versus reactive air surfaces: it is uncertain if there is any di erence between alternating pressure (active) air surfaces and reactive air surfaces in the proportion of participants developing a new pressure ulcer (6 studies, 1648 participants; very low-certainty evidence). When we considered time to pressure ulcer development as our primary outcome, we found that people using alternating pressure (active) air surfaces may be more likely to develop an incident pressure ulcer than those treated with reactive air surfaces over 14 days' follow-up in a nursing home setting (1 study, 308 participants; low-certainty evidence). For our secondary outcome, we are uncertain if there is a di erence in support-surface-associated patient comfort between alternating pressure (active) air surfaces and reactive air surfaces (4 studies, 1364 participants; very low-certainty evidence). • Alternating pressure air surfaces versus reactive water surfaces: it is uncertain if there is a di erence in the proportion of participants developing a new pressure ulcer between alternating pressure (active) air surfaces and reactive waterfilled surfaces (2 studies, 358 participants; very low-certainty evidence). We did not find data for our secondary outcomes. • Alternating pressure air surfaces versus reactive fibre surfaces: it is uncertain if there is a di erence in the proportion of participants developing a new pressure ulcer between alternating pressure (active) air surfaces and reactive fibre surfaces (3 studies, 285 participants; very low-certainty evidence). We also found it is uncertain if there is a di erence in support surface associated patient comfort between these support surfaces (1 study, 187 participants; very low-certainty evidence). • Alternating pressure (active) air surfaces on operating tables and subsequently on ward beds versus reactive gel surfaces used on operating tables followed by foam surfaces on ward beds. Alternating pressure (active) air surfaces applied on both operating tables and hospital beds may reduce the proportion of people developing a new pressure ulcer compared with reactive gel surfaces used on operating tables followed by foam surfaces applied on hospital beds (2 studies, 415 participants). However, this is low-certainty evidence. We are uncertain if there is any di erence in adverse events between these support surfaces (1 study, 198 participants; very low-certainty evidence). • Alternating pressure air surfaces versus alternating pressure air surfaces: we found low-certainty evidence suggesting little to no di erence in the risk of developing a new pressure ulcer when treated with di erent forms of alternating pressure (active) air surfaces (7 studies, 2833 participants). We are uncertain whether there is any di erence in supportsurface-associated patient comfort and adverse e ects between di erent forms of alternating pressure (active) air surfaces (very low-certainty evidence). There is moderate-certainty evidence that alternating pressure air mattresses are probably more coste ective than alternating pressure air overlays. Trusted evidence. Informed decisions. Better health. As detailed in Search methods for identification of studies, we ran a comprehensive set of literature searches to maximise the relevant research included here. Whilst use of support surfaces is relevant to adults and children, all participants in the included studies were adults (with the reported average age ranging from 37.2 to 87.0 years, median of 69.1 years). Across the included studies, more than half (55.6%) of enrolled participants were female. Almost all of the studies enrolled people who were at (high) risk of pressure ulceration (with risk assessed using a risk assessment tool (e.g. the Braden scale)), and who were ulcer-free at the time of recruitment. Nine of the included studies (with 4808 participants) did include participants with superficial pressure ulcers at baseline. Most of the included studies were small (half had fewer than 100 participants). Nine studies enrolled more than 200 participants (Andersen 1982; Aronovitch 1999; Beeckman 2019; Bliss 1995; Demarre 2012; Jiang 2014; Laurent 1998; Nixon 2006; Nixon 2019) , of which six studies enrolled more than 400 participants (Andersen 1982; Bliss 1995; Demarre 2012; Jiang 2014; Nixon 2006; Nixon 2019) . These six trials together accounted for 73% (6624/9058) of the participants in the review. The geographical scope of the included studies was limited. Almost all of the studies were from Europe and North America. Only one large trial was from China (Jiang 2014), and another one was from Japan (Sanada 2003). The included studies recruited participants from a variety of care settings including: acute care settings (19 studies); community and long-term care settings (nine studies), or both (one study), and intensive care units (three studies). Whilst five of the six comparisons included studies from a variety of care settings, due to a limited number of included studies for these four comparisons, we could not perform pre-specified subgroup analysis by di erent care settings. Thus, for these five comparisons, we are unable to drawn conclusions about potential modification of treatment e ects in di erent care settings. An exception to this is the comparison of the alternating pressure (active) air surface on operating tables and subsequently on the ward bed with the reactive gel surface on operating tables followed by the foam surface applied on ward beds. This evidence suggests the beneficial e ects of using alternating pressure (active) air surfaces on both operating tables and hospital ward beds. There were no data specifically for operating rooms. We recognise that alternating pressure (active) air surfaces can have a range of cell sizes (e.g. large cells, small cells) and other features (e.g. being able to operate as a hybrid surface switching between active and reactive modes; low-air-loss; see Appendix 4). In this review, we considered all these specific types (e.g. alternating pressure (active) low-air-loss surfaces, and hybrid air surfaces) as alternating pressure (active) air surfaces because they have the same underlying mechanism of redistributing pressure activity (i.e. mechanically alternating pressure). Some health professionals have expressed an interest in the e ectiveness of support surfaces defined as hybrid based on having a mixed composition of materials; for example, surfaces made from alternating pressure air cells on a foam layer as opposed to only air cells. When exploring the evidence in this way, we identified very limited evidence. Such exploration may be important for future work if deemed a clinical priority. We did not analyse data reported in another four studies comparing alternating pressure (active) air surfaces with 'standard hospital surfaces'. Those surfaces were labelled with that term by the original study authors, and we could not define them using the NPIAP S3I 2007 support surfaces terms and definitions. However, for completeness of all relevant evidence, we reported the data from these studies in Appendix 5. Another potential limitation in the included studies is the large variation in duration of follow-up (ranging from three days to 180 days, median of 14 days). This is partly because di erent follow-up durations are appropriate in di erent care settings. For example, participants staying in acute care settings are more likely to be discharged a er a short-term hospital stay, whilst those staying at community and long-term care settings will typically stay for longer. The short median duration of follow-up may contribute to an under-estimation of pressure ulcer incidence across study groups of the included studies because most pressure ulcers would occur in the first two to four weeks a er hospital admission (Schoonhoven 2007), and some incident pressure ulcers may have been missed in these studies. We implemented the GRADE approach for assessing the certainty of the evidence and found that most included evidence from our 19 meta-analyses or syntheses across six comparisons was of low and very low certainty. Downgrading of evidence was largely due to the high risk of bias of findings and imprecision due to small study sizes in terms of participants or event numbers, or both. There was also some inconsistency across studies and publication bias for some comparisons. We downgraded once or twice for study limitations for almost all evidence. We assessed risk of bias according to seven domains: sequence generation, allocation concealment, blinding of participants and personnel, blinding of outcome assessment, selective outcome reporting, incomplete follow-up, and other potential biases. Of the 32 studies, we judged 25 as being at high overall risk of bias, and only seven at unclear overall risk of bias. The prevalence of high overall risk of bias is partly due to the nonblinding of participants and personnel for most of comparisons. We acknowledged that such blinding of participants and personnel is impractical for almost all comparisons. Therefore, we did not downgrade certainty of evidence for studies at high overall risk of bias solely due to the possible presence of performance bias. Ten studies were also at high risk of bias due to unblinded outcome assessment. Unblinded assessment has been found to exaggerate odds ratios (from subjective binary outcomes) by, on average, 36% (Hróbjartsson 2012). The outcome assessment of pressure ulcer incidence is subjective and blinded assessment -whilst operationally challenging -can be undertaken; for example, through masked adjudication of photographs of pressure areas (Baumgarten 2009). Therefore, we considered unblinded pressure ulcer incidence assessment could substantially bias e ect estimates in the included studies and downgraded the certainty of evidence for detection bias on a study-by-study basis. In general, we considered that the participants, interventions, and outcomes in the included studies were within the scope of the published review protocol and there was no indirectness. Therefore, we did not downgrade for indirectness, with the exception of one piece of included evidence: the evidence for support-surface-associated patient comfort outcome in the comparison of alternating pressure (active) air surfaces versus reactive fibre surfaces. In the only included study for this outcome, the reason for dropout was considered as discomfort. Therefore, the evidence may not be directly relevant to the comfort outcome of this review. Statistical heterogeneity was low for most of the evidence syntheses (15/19) we performed and we did not downgrade for inconsistency for these pieces of evidence. The low statistical heterogeneity was partly because eight of the 19 syntheses included only one study. One of the 19 meta-analyses suggested some heterogeneity (I 2 = 63% in Analysis 1.1). However, we did not downgrade for inconsistency for this because our additional exploratory analyses suggested the heterogeneity could be well explained by excluding a study with an extreme value. We downgraded for inconsistency for the rest (four) of the meta-analyses or narrative syntheses. None of these four analyses included more than seven studies. Despite the fact that we found heterogeneity in terms of overall risk of bias, care settings, outcome measurement methods, or follow-up durations between their included studies, we investigated their heterogeneity using subgroup analysis and we considered their heterogeneity (inconsistency) unexplained. We have to note that, although we planned to calculate prediction intervals to understand the implications of heterogeneity, all analyses included a small number (up to seven) of included studies which was fewer than the 10 needed for this calculation. We downgraded once or twice for imprecision for most comparisons. Study sample sizes were small in most cases (median sample size: 83; range: 10 to 2029) with o en small numbers of events and wide associated confidence intervals around e ect estimates. Confidence intervals o en crossed the line of null e ect and RRs = 0.75 and/or 1.25, thus meaning we could not discern whether the true population e ect was likely to be beneficial or harmful. We did not downgrade the certainty of evidence for publication bias in almost all meta-analyses. This is because (1) we have confidence in the comprehensiveness of our literature searches; and (2) we did not find any clear evidence of non-reporting bias of study results. Although we planned to perform funnel plots for meta-analysis to visually inspect for publication bias, there was no analysis including more than ten studies. We followed pre-specified methods to review evidence in order to prevent potential bias in the review process. For example, we ran comprehensive electronic searches, searched trials registries, and checked the references of systematic reviews identified by the electronic searches. This review also has limitations. Firstly, some included studies may have considered co-interventions as 'usual care' but did not fully describe them. We assumed that all studies had provided cointerventions equally to participants in their study groups if there was nothing to indicate that this was not the case. Secondly, we did not implement pre-specified subgroup analysis, as mentioned above, mainly because no analysis included more than ten studies. Thirdly, we included a factorial design study -Laurent 1998 -in this review but did not consider the potential interaction between interventions. Fourthly, only Nixon 2019 reported HRs and CIs related to time-to-event data. The remaining HRs and CIs we used in related analyses were calculated using the methods described in Tierney 2007. We recognised that those calculated data (and associated meta-analyses) might be inaccurate. We noted that almost all time-to-event data analyses using the HRs and CIs we calculated appeared (or tended) to agree with associated binary data analyses as we expected. Fi hly, four studies described their controls as 'standard hospital surfaces' but did not specify the construction materials of these surfaces. Although we made e orts to collect information on these surfaces, we were not able to classify them. Traditionally, 'standard hospital surfaces' meant foam surfaces, but we felt adopting that assumption was unwarranted. Further classification of these surfaces might change the results of some comparisons; for example, alternating pressure (active) air surfaces versus foam surfaces. Finally, we were not able to pre-specify the comparisons included in this review. This is because specific support surfaces applied could only be known and defined once eligible studies were included. However, we preplanned to use the NPIAP S3I 2007 support surface terms and definitions to define specific support surfaces in order to avoid any potential bias. To our knowledge, among the 14 systematic reviews or metaanalyses we identified in electronic searches for this review ( This review di ers from Shi 2018a in how specific alternating pressure (active) air surfaces are classified. In this review, we consider them as a single generic group, whereas Shi 2018a considered alternating pressure (active) low-air-loss surfaces, hybrid air surfaces and generic alternating pressure (active) air surfaces as separate groups. Additionally, Shi 2018a grouped some interventions under the term 'standard hospital surfaces' but concluded that the types of surfaces labelled in this way varied over time, and by setting. In this review, we made great e orts to define surfaces where these surfaces were described as a 'standard hospital surface' in the included studies to ensure they were placed in the correct comparisons. This re-definition allowed us to define the 'conventional management' used in Aronovitch 1999 and Russell 2000 as reactive gel surfaces followed by foam surfaces, rather Cochrane Database of Systematic Reviews than standard hospital surfaces. We classified 'standard hospital surfaces' used in other studies as undefined surfaces. Shi 2018a reported moderate-certainty evidence favouring alternating pressure (active) air surfaces. The reasons above may explain some of the inconsistency between the reviews but, importantly, Shi 2018a was a network meta-analysis. Shi 2018a indicated an evidence gap around the comparison alternating pressure (active) air surfaces versus foam surfaces, and expected to tackle this gap by including a large, then ongoing study -Nixon 2019 -in data analysis. This review did include this study, but this still resulted in some uncertain evidence with the use of pairwise meta-analysis methods. Further planned review work using network meta-analysis will add to the findings reported here. The Cochrane Review McInnes 2015 grouped a variety of reactive surfaces ('Silicore overlay', a 'water mattress', a 'foam pad', and 'static air mattresses') into 'constant low-pressure devices', concluding that it was unclear whether alternating pressure (active) air surfaces impacted on incident pressure ulceration compared with these constant low-pressure devices. The conclusions of McInnes 2015 are generally consistent with our review but our review adds more granular findings to the evidence base. By using the NPIAP S3I terms for support surfaces, our review di erentiated reactive surfaces from each other, and presents separate analyses for each. Current evidence is uncertain about the di erence in pressure ulcer incidence between alternating pressure (active) air surfaces and other surfaces: reactive water surfaces, reactive fibre surfaces and reactive air surfaces. People using alternating pressure (active) air surfaces may reduce pressure ulcer incidence compared with those using foam surfaces. Also, alternating pressure (active) air surfaces applied on both operating tables and hospital beds may reduce pressure ulcer incidence compared with reactive gel surfaces used on operating tables followed by foam surfaces applied on hospital beds. However, people using alternating pressure (active) air surfaces may be more likely to develop an incident pressure ulcer than those treated with reactive air surfaces over 14 days' followup in a nursing home setting. Alternating pressure (active) air mattresses are probably more cost-e ective than overlay versions of this technology for people in acute care settings. Alternating pressure (active) air surfaces are probably more cost-e ective than foam surfaces for people in community and acute care settings. Given the large number of di erent support surfaces available, future studies should prioritise which support surfaces to evaluate on the basis of the priorities of decision-makers. For example, alternating pressure air surfaces versus reactive air surfaces may be a high priority for future evaluation. All interventions used should be clearly described using the current classification system, and researchers should avoid the use of generic terms such as 'standard hospital surfaces'. Limitations in included studies are largely due to small sample size and sub-optimal RCT design. The incidence of pressure ulcers can be low in certain settings and this needs to be considered in sample size calculations and when considering the feasibility of trial conduct. Under-recruitment or over-estimation of event rates that then fail to occur, or both, can lead to imprecision and less robust e ect estimates. Future studies should also consider carefully the choice of outcomes they report. Time-to-event data for pressure ulcer incidence should be used in studies. Careful and consistent assessment and reporting of adverse events needs to be undertaken to generate meaningful data that can be compared between studies. Likewise, patient comfort is an important outcome but poorly defined and reported, and this needs to be considered in future research studies. Further studies should aim to collect and report health-related quality of life using validated measures. Finally, future studies should nest cost-e ectiveness analysis in their conduct where possible. Any future studies must be undertaken to the highest standard possible. Whilst it is challenging to avoid the risk of performance bias in trials of support surfaces as blinding of participants and personnel is seldom possible, stringent protocols -for example, in terms of encouraging consistent care and blinded decision-making -can help to minimise the risk. It is also important to fully describe co-interventions (e.g. repositioning) and ensure protocols mandate balanced use of these across trial arms. The risk of detection bias can also be minimised with the use of digital photography and adjudicators of the photographs being masked to support surfaces (Baumgarten 2009). Follow-up periods should be for as long as possible and clinically relevant in di erent settings. Where possible and useful, data collection a er discharge from acute settings may be considered. (7) Methods Study objective: to observe "the development of pressure sores in risk-patients nursed on these mattresses [water-mattresses and alternating pressure air-mattresses and compare] the results with a similar group of patients nursed on ordinary hospital mattresses" Outcomes that are not considered in this review but reported in trials: 1. "opinions on mattresses" described as "the acceptability of the mattress" and rated as the numbers of sta satisfied and the numbers of patients satisfied with different mattresses. Alternating pressure ( Comment: appears to have no blinding, and the pressure ulcer incidence outcome measurement is likely to be influenced by lack of blinding. Incomplete outcome data (attrition bias) All outcomes Quote: "Six hundred patients at risk for pressure sores were randomised ..." Quote: "Among the 600 risk-patients ... 118 dropped out during the first 24 hours before the first dermatologic inspection. This did not impair randomization." Quote: "The groups remained comparable throughout the 10-day study period" Comment: unclear risk of bias was judged because authors claimed that randomisation was not impaired though the proportion of missing data was high and no reasons for missing data were provided. Selective reporting (reporting bias) Low risk Comment: the study protocol is not available but it is clear that the published reports include all expected outcomes, including those that were pre-specified. Other bias Low risk Comment: the study appears to be free of other sources of bias. Methods Study objective: "... to determine the efficacy and safety of the experimental system (study group), in comparison with conventional management (control group), for the prevention of pressure ulcers in the operative and postoperative settings" in the operating room on top of a standard operating room pad, and a Pressure Guard II hospital replacement mattress (Span-America Medical Systems, Inc., Spartanburg, SC) on the hospital bed" (Aronovitch 1999); for operating table, Action Pad (Action Products) consisting of AKTON® Viscoelastic polymer that looks and feels like a gel (www.actionproducts.com/media/files/Action_Sup-port_Surface_Brochure.pdf); a series of PressureGuard products identified from Span-America product catalogue (www.spanamerica.com/product-catalog-new.php) and the catalogue states "... every PressureGuard model combines the effectiveness of an air flotation system with the unmatched stability and safety of a multi-component engineered foam shell" • NPUAP S3I classification: non-powered, reactive gel surface; non-powered, reactive foam surface; applied sequentially Aronovitch 1999 (Continued) Alternating pressure ( Blinding of outcome assessment (detection bias) All outcomes Quote: "Patients were examined following surgery and daily for pressure ulcers, including number, stage (I-IV), size (area), location, and appearance." Comment: insufficient information to permit judgement of low or high risk of bias. Incomplete outcome data (attrition bias) All outcomes Quote: "Seven patients (8.75%) in the control group developed a total of 11 pressure ulcers ..." Comment: high risk of bias because 7 (8.75%) in control group implied 80 of 105 individuals were considered in data analysis, meaning a large proportion of missing data in the control group alone. However, the number of available cases in experimental group is not given. Selective reporting (reporting bias) Low risk Comment: the study protocol is not available but it is clear that the published reports include all expected outcomes, including those that were pre-specified. Other bias Low risk Comment: the study appears to be free of other sources of bias. Methods Study objective: to evaluate two alternating-pressure mattresses for patient comfort and quality of sleep Total number of participants: n = 10 Interventions Debut MR mattress • Description of interventions: Debut MR (SSI Hill-Rom) mattress, unlike the rigid tubes of conventional alternating pressure mattresses (APMs), has a different type of cushion design incorporating 20% extra material that allows the patient to sink into the mattress, resulting in further distribution of the body weight. The 28 air cushions inflate and deflate on a one-in-four alternating cycle lasting 30 minutes ... The mattress will operate in a static mode but this is recommended for transport only • NPUAP S3I classification: powered, alternating pressure (active) air surface • Co-interventions: not described self-reported; measured by using a 15-point standardised questionnaire and a visual rating scale (rating from very uncomfortable to very comfortable) • Definition: the level of comfort of mattresses experienced by older people • Dropouts: one withdrew during the study and another person recruited • Notes: "Five recruits to the study found the Debut mattress more comfortable than their normal bed, while six found the Nimbus mattress less comfortable than their normal bed"; "there was a strong preference for the Debut over the Nimbus mattress and this difference was statistically significant (Wilcoxon signed ranks exact test p = 0.019)"; "Overall 8/10 preferred the Debut mattress for both sleep quality and comfort" All reported adverse events using allocated support surfaces • Not reported Ballard 1997 (Continued) Alternating pressure ( Low risk Comment: the study protocol is not available but it is clear that the published reports include all expected outcomes, including those that were pre-specified. Other bias Low risk Comment: the study appears to be free of other sources of bias. Methods Study objective: to compare the effectiveness and cost of static air support surfaces versus alternating air pressure support surfaces in a nursing home population at high risk for pressure ulcers (1) high risk of developing pressure ulcer (Braden score 12 and/or Braden subscale score for mobility 2) and/or pressure ulcer category 1; (2) being bed bound (> 8 hours in bed) and/or chair bound (> 8 hours sitting in a chair); (3) aged > 65 years; and (4) use of an alternating air pressure mattress Exclusion criteria: (1) nursing home residents with a pressure ulcer category II-IV upon admission; (2) those with an expected length of stay < 2 weeks; (3) those who received end-of-life care; or (4) Random sequence generation (selection bias) Low risk Quote: "The random allocation sequence was based on a computer-generated list of random numbers using an online tool (www.randomization.com)." Comment: low risk of bias because of the use of a proper randomisation method. Alternating pressure ( Allocation concealment (selection bias) Unclear risk Quote: "When the participants met the inclusion criteria and an informed consent was obtained, they received an allocation number (first available number on the computer-generated list)." Quote: "Subsequently, a random allocation of each eligible participant was performed based on a computer-generated list of random numbers." Comment: unclear risk of bias because the process of allocation is not clear for judging if concealment was properly performed and it is unclear who performed allocation. Blinding of participants and personnel (performance bias) All outcomes Quote: "The study was not blinded due to the obvious visible difference between the support surfaces (e.g. external control unit)." Comment: high risk of bias because of the understandable challenge of performing blinding. Blinding of outcome assessment (detection bias) All outcomes Quote: "The study was not blinded due to the obvious visible difference between the support surfaces (e.g. external control unit). Both support surface types were presented to ward nurses ..." Quote: "During the follow-up period (days 1-14), the ward nurses collected all data" Quote: "Researchers performed independent and unannounced skin assessments and technical controls weekly" Comment: high risk of bias because of the understandable challenge of performing blinding. Incomplete outcome data (attrition bias) All outcomes Low risk Quote: "An intention-to-treat analysis was performed." Comment: low risk of bias. Selective reporting (reporting bias) Low risk Comment: the study protocol is available and it is clear that the published reports include all outcomes, including those that were pre-specified. Other bias Low risk Comment: the study appears to be free of other sources of bias. Methods Study objective: to assess different mattresses for preventing pressure sores Setting: geriatric unit Participants Inclusion criteria: all new patients with a Norton score of 7 or more, and all inpatients with a score 7 or more and still rising, provided they had no, or only superficial, trunk sores at the time Health-related quality of life (HRQOL) • Not reported • Not reported Outcomes that are not considered in this review but reported in trials: • Deficiencies of the ripple bed machine (n = 3) • Ulcer changes among those with existing ulcers at baseline Random sequence generation (selection bias) Unclear risk Quote: "In order to ensure that the distribution of subjects among the various regimens was as random as possible the experimental and control treatments were arranged in a rota. As patients were admitted to the trial they were allocated to the next treatment on the rota in order" Comment: unclear risk of bias because the sequence generation process is not described • Not reported • Not reported Random sequence generation (selection bias) Low risk Quote: "the patient was randomly allocated to an experimental overlay by the researcher writing the names of all those available at the time on slips of paper which were folded and offered to the nurse to choose one blind" Comment: low risk of bias because drawing of lots is applied to generate random sequence. High risk Quote: "the patient was randomly allocated to an experimental overlay by the researcher writing the names of all those available at the time on slips of paper which were folded and offered to the nurse to choose one blind. The designated overlay was then placed on the bed" Comment: high risk of bias because it appears difficult to conceal the allocation process as the authors described. The nurse would have knowledge of which overlays were available at the time of consent. Blinding of participants and personnel (performance bias) All outcomes Unclear Cochrane Database of Systematic Reviews Selective reporting (reporting bias) Low risk Comment: the study protocol is not available but it is clear that the published reports include all expected outcomes, including those that were pre-specified. Other bias High risk Comment: high risk of bias because some individuals may be repeatedly observed and included in analysis (i.e. correlation issue in analysis). For example, Bliss stated "there were no written criteria determining the decision to stop a trial [i.e. using an overlay as the experimental intervention]. This depended mainly on these experienced nurses' unwillingness to allow it to continue because of enlargement of an existing sore, a new blister, discolouration, oedema ... Patients who developed pressure damage between assessments might also be taken o their overlay ... if they later improved ... they were re-randomized for another trial period [i.e. comparisons of new overlays]" Additionally, overlays were observed for unequal periods of time. Treatments were discontinued or introduced without pre-specified stopping rules. Some comparisons are not parallel. Methods Study objective: to determine whether alternating low pressure or continuous low pressure is most effective in reducing the incidence of pressure ulcers in high risk patients Inclusion criteria: those admitted to the unit or deemed "at risk" of pressure ulceration as defined by the Braden Pressure Ulcer Risk Assessment Scale (a total Braden score of ≤ 17 and mobility and activity sub-scores of ≤ 3 respectively); their admission was expected to last at least 2 weeks and they had up to one grade I pressure ulcer Cochrane Database of Systematic Reviews Interventions Alternating low pressure modality of Duo2 (Hill-Rom) • Description of interventions: Duo2 (Hill-Rom), "... electrically powered, air-filled mattresses in which adjacent cells inflate and deflate reciprocally underneath the patient" • NPUAP S3I classification: powered, alternating pressure (active) air surface • Co-interventions: not described • Dropouts: 17 dropouts in alternating low pressure (4 died, 8 discharged prior to assessment, 5 did not complete study due to non-concordance (uncomfortable) and not agreeing to use the modality; 13 dropouts in continuous low pressure (5 died, 4 discharged prior to assessment, 4 did not complete study due to non-concordance and not agreeing to use the modality). • Reporting: not reported • Notes: 5 dropouts due to discomfort and/or not agreeing to use the assigned modality in alternating low pressure; 4 dropouts due to discomfort and/or not agreeing to use the assigned modality in continuous low pressure. All reported adverse events using allocated support surfaces Cochrane Database of Systematic Reviews Random sequence generation (selection bias) Unclear risk Quote: "Patients in the treatment group were randomised to receive either continuous or alternating low pressure on the high-tech mattress" Comment: the method of randomisation was not reported. Allocation concealment (selection bias) Unclear risk Comment: no information provided Blinding of participants and personnel (performance bias) All outcomes Quote: "... independently from the blinded randomised treatment group (who received the Duo2 high-tech mattress)." Comment: low risk of bias because blinding method was implemented. Blinding of outcome assessment (detection bias) All outcomes Outcome group: primary outcome Quote: "As there is no visible difference between these two modes, the external observer was blinded as to which one was in use. The external observers assessed all study patients' ... presence (or absence) and grade of both existing and new pressure ulcers" Comment: low risk of bias because outcome assessment was blinded. Incomplete outcome data (attrition bias) All outcomes Comment: high risk of bias because of high proportions of dropouts in both groups and probably using incorrect analysis methods to address missing data. Selective reporting (reporting bias) Low risk Comment: the study protocol is not available but it is clear that the published reports include all expected outcomes, including those that were pre-specified. Other bias Low risk Comment: the study appears to be free of other sources of bias. Study objective: to determine the efficacy of the alternating air mattress overlay and the silicone mattress overlay in preventing pressure ulcers Cochrane Library Trusted evidence. Informed decisions. Better health. Setting: extended care facility for neurological conditions Participants Inclusion criteria: patients in extended care facility for neurological conditions, 18 to 55 years old, with no evidence of skin breakdown for at least 2 weeks prior to the study, and who were at high risk of developing ulcers according to the Norton's Scale (i.e. less than the score of 14) Exclusion criteria: the status of high risk changed during the study • Reporting: not reported • Notes: total overall cost per year of use presented in cost analysis paper by overlay groups: USD 771 in air overlay group and USD 500 in silicone overlay group • Healing duration of ulcers • Severity of new ulcers • Acceptability measured for 40 patients in total (20 from each group) Random sequence generation (selection bias) Unclear risk Quote: "A modified sequential clinical trial ... was used to assign subjects randomly to one of the two mattresses in groups of 20" Comment: the method of randomisation was not specified. Unclear Cochrane Database of Systematic Reviews Comment: low risk of bias because blinding is likely applied. Incomplete outcome data (attrition bias) All outcomes Quote: "Thirty-nine subjects did not complete the trial for reasons shown in Table 3 " Comment: high risk of bias because over 20% of 187 randomised individuals missed and most of the dropouts were due to discomfort. Selective reporting (reporting bias) Low risk Comment: the study protocol is not available but it is clear that the published reports include all expected outcomes, including those that were pre-specified. Other bias Low risk Comment: the study appears to be free of other sources of bias. Methods Study objective: to assess 2 commonly used special mattresses in a randomised trial involving adult non-geriatric chronic neurologic patients Interventions Alternating air mattress • Description of interventions: "... consisted of an electrically driven pump connected to a heavy-duty plastic mattress ... composed of honey combed 4-inch air cells, which alternately inflate and deflate when in operation ... placed over a standard hospital spring mattress or 4-inch foam mattress and supported by a standard hospital bed frame" • NPUAP S3I classification: powered, alternating pressure (active) air surface • Co-interventions: usual care including repositioning and additional preventive aids (including heel and ankle protectors, sheepskins and bed cradles) Outcomes that are not considered in this review but reported in trials: • Equipment condition Random sequence generation (selection bias) Unclear risk Quote: "All were randomly assigned to one of the two types of mattresses" Comment: the method of randomisation was not described. Unclear risk Comment: no information provided. Blinding of participants and personnel (performance bias) All outcomes Comment: no information provided. Blinding of outcome assessment (detection bias) All outcomes Quote: "one of the investigators (DD) conducted weekly skin checks of the subjects" Comment: high risk of bias for pressure ulcer incidence outcome because it is unlikely that the investigator who assessed skin conditions was blinded. Incomplete outcome data (attrition bias) All outcomes Quote: "Thirty-two patients met the criteria for this study ... all admitted to the trial and completed it" Comment: no missing data. Selective reporting (reporting bias) Low risk Comment: the study protocol is not available but it is clear that the published reports include all expected outcomes, including those that were pre-specified. Other bias Low risk Comment: the study appears to be free of other sources of bias. Methods Study objective: to compare the effectiveness of an alternating low pressure air mattress with a standard single-stage inflation and deflation cycle of the air cells with an alternating low pressure air mattress with multi-stage inflation and deflation cycle of the air cells Single centre or multi-site: multi-site Setting: 25 wards in 5 hospitals in Belgium. Inclusion criteria: patients at risk for pressure ulcer development according to the Braden scale (less than 17), including those with non-blanchable erythema Exclusion criteria: patients with a pressure ulcer Grade II to IV on admission, the expected admission time < 3 days; aged < 18 years; with a "do not resuscitate code" specifying ending all therapeutic interventions, weight < 30 kg or > 160 kg, and informed consent not obtained Interventions Multi-stage alternating air mattress • Description of interventions: alternating air mattress with the multi-stage inflation and deflation of air cells (Hill-Rom ClinActiv). Three air cells with a continuous low pressure on head zone. Seven cells with a continuous ultra low pressure on heel zone. Ten alternating low pressure cells on back and sacrum zone. Ten-to twelve-minute cycle times for inflation and deflation and the air cells width 10 centimetres • NPUAP S3I classification: powered, alternating pressure (active) air surface • Co-interventions: not described • Number of participants randomised: n = 298 • Number of participants analysed: n = 298 (intention-to-treat (ITT) analysis) • Description of interventions: standard alternating air mattress (Hill-Rom Alto mattress), an alternating air mattress with a standard single-stage, steep inflation and deflation of the air cells. All air cells were alternating, the cycle time was 10 minutes and the air cell width was 10 centimetres. • NPUAP S3I classification: powered, alternating pressure (active) air surface • Co-interventions: not described • Number of participants randomised: n = 312 • Number of participants analysed: n = 312 (ITT analysis) Proportion of participants developing a new pressure ulcer presented as exclusion reasons. Eleven of 298 individuals withdrawing due to discomfort in multi-stage group and 0 exclusion due to consent; 16 of 312 due to discomfort and 1 due to consent in single-stage. • Reporting: not reported • Reporting: not reported • Reporting: not reported Random sequence generation (selection bias) Low risk Quote: "Included patients were randomly assigned to the study groups using simple randomisation. The random allocation sequence was based on a computer-generated list of random numbers" Comment: low risk of bias because of the use of a proper random sequence generation method. Alternating pressure ( Allocation concealment (selection bias) Low risk Quote: "Patients were enrolled by the ward nurses ... assigned to one of the mattresses by contacting the researcher. The ward nurse received a number of the type of allocated mattress" Comment: low risk of bias because it is likely that allocation sequence was concealed. Blinding of participants and personnel (performance bias) All outcomes Quote: "Both mattresses were covered with an identical mattress cover ..." Quote: "The study could not be blinded, because of the visible differences of the external control unit of the study mattresses" Comment: high risk of bias because it is unlikely that participants were blinded. Blinding of outcome assessment (detection bias) All outcomes Quote: "Daily skin assessment was performed by the ward nurses ... in each patient, in the morning" Quote: "No information was provided to the ward nurses about the differences between the experimental and control study device" Quote: "The lack of a blinded outcome assessment is a first limitation ... the nurses were not informed about the differences in the mattresses in order to minimize the effect of non-blinding" Comment: unclear risk of bias because efforts were made to reduce bias. Comment: high risk of bias because it is unlikely that patients who reported this outcome were blinded. Incomplete outcome data (attrition bias) All outcomes Low risk Outcome group: all outcomes Comment: low risk of bias because ITT analysis was undertaken. Selective reporting (reporting bias) Low risk Comment: the study protocol is not available but it is clear that the published reports include all expected outcomes, including those that were pre-specified. Other bias Low risk Comment: the study appears to be free of other sources of bias. Methods Study objective: to compare the effectiveness of a specialised alternating air pressure mattress replacement system and an air-fluidised integrated bed in the management of post-operative flap patients Inclusion criteria: 18 years or older who were admitted for reconstructive surgery to repair a tissue deficit (full-thickness pressure ulcer involving muscle, fascia and, in some cases, bone) in the sacralcoccygeal, trochanteric or ischial region. Exclusion criteria: unlikely or unwilling to comply with the treatment protocol, which included a minimum of 7 days bed rest within the surgical unit, or unable to consent. • Reporting: not reported • Reporting: not reported • Reporting: not reported • Notes: cost of support surface provision based on rental costs per day of inpatient care (USD 35/day for alternating therapy; USD 65/day for air-fluidised bed) • Integrity of the surgical site. Random sequence generation (selection bias) Low risk Quote: "allocation was determined by using web-based random-number software" Comment: low risk of bias due to the use of a proper randomisation method. Unclear risk Quote: "Groups were concealed in sealed envelopes" Comment: unclear risk of bias because a proper concealment method is not specified. Alternating pressure ( Blinding of participants and personnel (performance bias) All outcomes Comment: no information provided. Blinding of outcome assessment (detection bias) All outcomes Quote: "Tissue integrity on discharge was not blinded and determined by the surgical team responsible for this pilot phase." Comment: high risk of bias because no blinding was undertaken. Comment: unclear risk of bias because it is not specified if patients who reported comfort data were blinded. Incomplete outcome data (attrition bias) All outcomes Unclear risk Outcome group: all outcomes. Quote: "four subjects in Group A and three subjects in Group B did not receive the allocated intervention (Fig. 2) and were not included in the follow-up" Comment: unclear risk of bias because a fair proportion of subjects lost to follow-up. Selective reporting (reporting bias) Low risk Comment: the study protocol is not available but it is clear that the published reports include all expected outcomes, including those that were pre-specified. Other bias Low risk Comment: the study appears to be free of other sources of bias. Methods Study objective: to determine the effect of using the Softform Premier Active™ Mattress versus a standard air mattress on pressure ulcer incidence in 2 acute care of the elderly wards • Not reported • Not reported Outcomes that are not considered in this review but reported in trials: • Patient acceptability rated by sta nurses Random sequence generation (selection bias) Unclear risk Quote: "Patients considered to be at high risk of pressure ulcer development were randomly allocated to a Softform Premier Active or standard air mattress" Comment: unclear risk of bias because the sequence generation process is not described. Unclear risk Comment: no information provided. Blinding of participants and personnel (performance bias) All outcomes Unclear risk Comment: no information provided. Blinding of outcome assessment (detection bias) All outcomes Unclear risk Outcome group: ulcer incidence Quote: "Any pressure ulcers that developed during the study period were graded by a member of the tissue viability department." Comment: unclear risk of bias because blinding of outcome assessment is not described. Incomplete outcome data (attrition bias) All outcomes Unclear risk Outcome group: ulcer incidence Comment: unclear risk of bias because the numbers randomised to arms are not detailed. Selective reporting (reporting bias) Low risk Comment: the study protocol is not available but it is clear that the published reports include all expected outcomes, including those that were pre-specified. Other bias Low risk Comment: the study appears to be free of other sources of bias. Methods Duration of follow-up: 3 days (the first stage of the cross-over trial) Single centre or multi-site: single centre Study start date and end date: not described Inclusion criteria: patients with existing pressure sores grade 2* or above or patients without existing pressure sores but at high or very high risk of developing pressure sores (Waterlow risk assessment score of 15 or above); minimum anticipated hospice stay of 7 days; patients spending more than 6 hours in a 24-hour period on the mattress; patients must give consent • Not reported • Not reported • Not reported Outcomes that are not considered in this review but reported in trials: • Sleeping quality Notes Challenging to contact the study authors to request data at the first stage of this cross-over trial. Random sequence generation (selection bias) Low risk Quote: "Randomization was performed using a random numbers table" Comment: low risk of bias because the sequence generation process is proper. Low risk Quote: "To avoid bias, the order in which the mattresses were allocated was randomised and selected by the investigator from sealed opaque envelopes in sequential order." Comment: low risk of bias because it is likely to conceal allocation properly. Blinding of participants and personnel (performance bias) All outcomes Unclear risk Comment: no information provided. Blinding of outcome assessment (detection bias) All outcomes Unclear Cochrane Database of Systematic Reviews All outcomes Comment: unclear risk of bias because no information given on which group the missing are from. Selective reporting (reporting bias) Low risk Comment: the study protocol is not available but it is clear that the published reports include all expected outcomes, including those that were pre-specified. Other bias Low risk Comment: the study appears to be free of other sources of bias. Methods Study objective: not described Random sequence generation (selection bias) Unclear risk Quote: "Over a 4-month period, 36 patients were allocated to rhe Cairwave Therapy System during the randomised controlled trial" Comment: the method of randomisation was not described. Unclear risk Quote: "Over a 4-month period, 36 patients were allocated to rhe Cairwave Therapy System during the randomised controlled trial" Comment: the method of concealing allocation was not described. Blinding of participants and personnel (performance bias) • Not reported Random sequence generation (selection bias) Low risk Quote: "We used a random number table to randomize and parallel control design" Comment: low risk of bias because the sequence generation process is proper. Unclear risk Comment: no information provided. Blinding of participants and personnel (performance bias) All outcomes Unclear risk Comment: no information provided. Blinding of outcome assessment (detection bias) All outcomes Unclear risk Comment: no information provided. Incomplete outcome data (attrition bias) All outcomes Low risk Outcome group: ulcer incidence Comment: low risk of bias because intention-to-treat (ITT) analysis performed. Outcome group: comfort Comment: unclear risk of bias because the rates of missing data in both groups are between 10% to 20%. Selective reporting (reporting bias) Low risk Comment: the study protocol is not available but it is clear that the published reports include all expected outcomes, including those that were pre-specified. Other bias Low risk Comment: the study appears to be free of other sources of bias. Methods Study objective: to assess the effectiveness of 3 prevention strategies and compare them to the standard mattress Cochrane Database of Systematic Reviews Comment: high risk of bias as the above statement suggests. Incomplete outcome data (attrition bias) All outcomes Comment: no attrition identified. Selective reporting (reporting bias) Low risk Comment: the study protocol is not available but it is clear that the published reports include all expected outcomes, including those that were pre-specified. Other bias High risk Comment: the study appears not to consider the interaction between the effects of the different interventions that results from the factorial design used. Study objective: to compare pressure ulcer outcomes in medical intensive care unit (ICU) patients nursed on either a reactive mattress overlay (ROHO®, ROHO Inc, Belleville, IL, USA) or an active alternating pressure mattress (NIMBUS®3, ArjoHuntleigh, Luton Bedfordshire, UK) Duration of follow-up: not specified; mean study duration reported 12.2 days (SD 5.5) in ROHO and 15 (14) in NIMBUS 3 Single centre or multi-site: single centre Cochrane Database of Systematic Reviews Random sequence generation (selection bias) Low risk Quote: "Randomisation of patients to products was performed blinded by the insertion of equivalent numbers of labels written with 'active' or 'reactive' placed in identical sealed envelopes that were shuffled and placed in a box and drawn in sequence" Comment: low risk of bias because a simple randomisation was applied. Unclear risk Quote: "Randomisation of patients to products was performed blinded by the insertion of equivalent numbers of labels written with 'active' or 'reactive' placed in identical sealed envelopes that were shuffled and placed in a box and drawn in sequence. When a patient was admitted who fulfilled the inclusion criteria the next envelope was opened by a ward nurse and the patient was assigned to the mattress on the label" Low risk Comment: the study protocol is not available but it is clear that the published reports include all expected outcomes, including those that were pre-specified. Other bias Low risk Comment: the study appears to be free of other sources of bias. Methods Study objective: to compare whether differences exist between alternating pressure overlays and alternating pressure mattresses in the development of new pressure ulcers, healing of existing pressure ulcers, and patient acceptability. from ward sta and healthcare records) • Definition: adverse events due to support surfaces allocated • Dropouts: not relevant • Notes: 377 adverse events reported for 308 patients that were not reported by study groups; 10 patients with mattress-related events in mattress and 4 in overlay; 'not mattress related' adverse events also reported, but not extracted (see the primary reference of Nixon 2006). • Reporting: partially reported • Definition: how patients, after discharged, perceive and describe their health and quality of life, their experiences of developing a pressure ulcer and their experiences of pressure area care. • Notes: HRQOL measured and reported as qualitative analysis results. Participants of the qualitative interviews were 23 people with experience of having a pressure ulcer, but not limited to those eligible for this trial. From patients' perspectives, the development of a pressure ulcer has physical, emotional, mental and social impacts. The development of a pressure ulcer can be pivotal in the patient's tra- Trusted evidence. Informed decisions. Better health. Cochrane Database of Systematic Reviews jectory from illness to recovery, with the development of an ulcer preventing them from making a full recovery and causing varied impacts on their quality of life. • Outcome type: continuous • Reporting: fully reported in the primary reference of Nixon 2006 • Measurement method (e.g. scale, self-reporting): health benefit measures using Kaplan Meier estimates of restricted mean time to development of pressure ulcers. Overall costs at pricing year of 2002-3 included hospital treatment costs per day based on estimates from the Chartered Institute of Public Finance and Accountancy; unit purchasing and rental costs of each surface based on UK retail prices provided by the manufacturers. Hopsital costs analysed by using generalised linear model. Economic analysis from the perspective of the UK NHS and Personal Social Service; no cost or benefit discounting due to time horizon shorter than 1 year; non-parametric bootstrapping techniques applied; sampling uncertainty explored in an incremental cost effectiveness plane; sensitivity analysis conducted for 3 different scenarios. • Definition: incremental cost-effectiveness ratio (ICER), the ratio of the difference in costs relative to the difference in health benefit associated with the technology under evaluation. • Notes: because dominance was identified, an incremental analysis is not justified and the estimates of differential costs and health benefits were not combined in an ICER. Base case analysis results: mean overall hospital costs 6793.33 (SD 8196.52) in overlay group and 6509.73 (7347.56) in mattress group and mean difference in total hospital cost of £283.60 (95% confidence interval £377.59 to £976.79, P = 0.418). Difference in the Kaplan Meier restricted estimates of the mean time to development of pressure ulcers -10.64 days (95% bias corrected confidence interval 24.40 to 3.09 days; overlay versus mattress). The mattresses are a dominant strategy when compared with the overlays; they are associated with a delay in the development of pressure ulcers and lower hospital costs. Cost-effectiveness acceptability curve indicated that on average alternating pressure mattresses compared with alternating pressure overlays were associated with an 80% probability of being cost saving. • Time to healing and grade of ulcer at trial completion. • Healing of existing pressure ulcers. Random sequence generation (selection bias) Low risk Quote: "Randomisation was through an independent, secure, 24 hour randomisation automated telephone system, ensuring allocation concealment. We used minimisation so that groups were comparable. We minimised on centre, existing pressure ulcer ... specialty ... and type of admission" Comment: low risk of bias due to the use of a proper randomisation method. Low risk Quote: "Randomisation was through an independent, secure, 24 hour randomisation automated telephone system, ensuring allocation concealment. We used minimisation so that groups were comparable. We minimised on centre, existing pressure ulcer ... specialty ... and type of admission" Comment: low risk of bias due to proper concealment. Blinding of participants and personnel (performance bias) All outcomes Quote: "This was an open trial. Owing to the nature of the mattresses under investigation, it was not possible to mask the randomised intervention to the patients participating in the trial, ward nursing sta or the CRNs conducting the skin assessments" Library Trusted evidence. Informed decisions. Better health. Quote: "The PRESSURE Trial CRNs worked closely with ward sta and informed ward sta of the randomised mattress allocation" Comment: high risk of bias because it was impossible to blind participants and personnel but some efforts were made to improve the compliance of using the allocated interventions. Blinding of outcome assessment (detection bias) All outcomes Outcome group: primary outcome Quote: "This was an open trial. Owing to the nature of the mattresses under investigation, it was not possible to mask the randomised intervention to the patients participating in the trial, ward nursing sta or the CRNs conducting the skin assessments ... To minimise the potential for bias it was planned that qualified ward-based nursing sta (WNs) would record daily skin assessments and CRNs would undertake assessments twice weekly to validate ward sta records, ward sta remaining blind to the CRN record" (HTA report). Comment: unclear risk of bias because of the efforts to reduce detection bias. Outcome group: adverse event Quote: "Adverse events were reviewed by the clinical coordinator, TMG and TSC, who were blind to allocation" Comment: low risk of bias for adverse event outcome. Incomplete outcome data (attrition bias) All outcomes Quote: "The analysis was by intention to treat, with participants being analysed according to the group to which they were randomised ..." Quote: "... 1972 were randomised ... One patient was randomised twice and therefore excluded, providing an intention to treat population of 1971 people ..." Comment: low risk of bias because intention-to-treat analysis was done. Selective reporting (reporting bias) Low risk Comment: the study protocol is available and all of the study's pre-specified (primary and secondary) outcomes that are of interest in the review have been reported in the pre-specified way. Other bias Low risk Comment: the study appears to be free of other sources of bias. Methods Study objective: to compare the clinical effectiveness and cost-effectiveness of 2 mattress types: alternating pressure mattresses (APMs) or high specification foam (HSF) Trusted evidence. Informed decisions. Better health. Setting: 42 UK secondary/community inpatient facilities Participants Inclusion criteria: inpatient with evidence of acute illness; ≥ 18 years; expected stay ≥ 5 days; expected to comply with follow-up; on electric profiling bed-frame; high pressure ulcer (PU) risk due to at least 1 of following: Braden activity score 1/2 and mobility score 1/2; category 1 ulcers; localised skin pain on a healthy/altered/category 1 pressure area Exclusion criteria: had previously participated; current/previous ulcer category ≥ 3; planned intensive care unit (ICU) admission; unable to receive intervention; outside mattress weight limits (< 45 kg or > 180 kg); ethically inappropriate e.g. thought to be in the last few days of their life Interventions Alternating pressure air mattress (APM) • Description of interventions: fully automatic; some may have dual therapy, for example, the mattress comprises a combination of alternating pressure or low-air-loss. The trial will include only those participants nursed on the alternating pressure mode of action, with a 7.5 to 30 minute cycle time. • NPIAP S3I classification: powered, alternating pressure (active) air surface • Co-interventions: not reported • Number of participants randomised: n = 1017 • Number of participants analysed: n = 1016 High-specification foam mattress (HSF) • Description of interventions: be high-density foam, viscoelastic (memory) foam or a combination of both, and can be castellated (for ventilation and profiling); have a cover with the following characteristics: removable, minimum two-way stretch, vapour permeable and covered zips as defined in BS 3379.36; be replacement mattresses with a minimum depth of 150 to 200 mm • NPIAP S3I classification: non-powered, reactive foam surface • Definition (including ulcer stage): incidence of PU category ≥ 2 from randomisation to 30 days from the end of the treatment phase (maximum of 90 days) • Dropouts: intention-to-treat (ITT) analysis but 1 participant excluded from alternating pressure mattress due to their previous inclusion/randomisation • Outcome type: binary and Personal Social Services (PSS). The NICE GBP (pounds sterling) 20,000 per QALY gained threshold was used to determined cost-effectiveness. Utility values were derived from the EQ-5D-5L, and costs were estimated using the UK tariff. Costs and outcomes were adjusted for baseline imbalances. Sampling uncertainty was determined via a probabilistic sensitivity analysis (PSA) using a non-parametric bootstrap. • Definition (including ulcer stage): the incremental cost per QALY gained; within-trial analyses using QALYs derived from the EQ-5D-5L • Drop outs: ITT analysis • Notes (e.g. other results reported): adjusted for baseline costs and QALYs, deterministic analysis suggests the mean total costs of APM and HSFM are GBP 4,533 and GBP 4,646, respectively, with mean QALYs of 0.128 and 0.127, respectively. ICER = GBP -136,171; NMB = GBP -2,077; probabilistic analysis shows mean total costs of APM and HSFM are GBP 4,533 and GBP 4,646, respectively, and mean QALYs are 0.128 and 0.127, respectively. ICER = GBP -101,699 and NMB = GBP -2,114. Estimates indicate that APM has a 99% probability of being cost-effective at a threshold of GBP 20,000 (APMs dominate HSFM, as APM has lower costs and higher QALY values). Lifetime decision-analytic model developed for lifetime cost-effectiveness analysis but data not extracted for this review. Finding is: APM is cost-effective over both the short and the long term. • Time to healing of all pre-existing category 2 ulcers • Mattress compliance Random sequence generation (selection bias) Low risk Quote: "Participants were randomised centrally (24 h automated telephone system, ensuring allocation concealment) on a 1:1 basis using minimisation (with random element) and minimisation factors: centre, PU status, type of facility, and type of consent" Comment: low risk of bias because of the use of a proper randomisation method. Low risk Quote: "Participants were randomised centrally (24 h automated telephone system, ensuring allocation concealment) on a 1:1 basis using minimisation (with random element) and minimisation factors: centre, PU status, type of facility, and type of consent" Comment: low risk of bias because allocation is properly concealed. Blinding of participants and personnel (performance bias) Trusted evidence. Informed decisions. Better health. All outcomes Blinding of outcome assessment (detection bias) All outcomes Low risk Quote: "Assessment of risk of bias of the primary endpoint was done with central blind review of photographs and a 10% sample of patients who had skin assessments by a practitioner blinded to previous assessments was performed" Comment: low risk of bias because attempts were made to mask outcome assessment. Incomplete outcome data (attrition bias) All outcomes Low risk Quote: "All participants recruited were included using Intention-To-Treat (ITT) and analysed by randomised allocation" Comment: low risk of bias because ITT analysis was performed. Selective reporting (reporting bias) Low risk Comment: the study protocol is available and it is clear that the published reports include all outcomes, including those that were pre-specified. Other bias Low risk Comment: the study appears to be free of other sources of bias. Methods Study objective: to compare the mattress overlay system with a second dynamic overlay Study design: randomised n-of-1 controlled trial, with a series design Cochrane Database of Systematic Reviews Viaclin dynamic mattress overlay • Description of interventions: Viaclin dynamic mattress overlay (formerly known as the Overture dynamic mattress overlay) consisting of 18 alternating pressure air cells ... manufactured in polyurethane (PU)-coated nylon ... overlay cells inflate and deflate over a 12-minute cycle by means of an electro-pneumatic system • NPIAP S3I classification: powered, alternating pressure (active) air surface • Co-interventions: not described • Not reported • Not reported Phillips 1999 (Continued) Alternating pressure (active) air surfaces for preventing pressure ulcers ( Random sequence generation (selection bias) Unclear risk Quote: "On entry to the study, subjects were randomly allocated to either the Viaclin or an alternative dynamic overlay" Comment: unclear risk of bias because the sequence generation process is not described. Unclear risk Comment: no information provided. Blinding of participants and personnel (performance bias) All outcomes Unclear risk Comment: no information provided. Blinding of outcome assessment (detection bias) All outcomes Unclear risk Comment: no information provided. Incomplete outcome data (attrition bias) All outcomes Unclear risk Comment: unclear risk of bias because data prior to cross-over were not available. During the trials, 19 patients withdrew before the end of the trial. Selective reporting (reporting bias) High risk Comment: the study protocol is not available but it is clear that the published reports include all expected outcomes. We expected to see outcomes reported by randomised group per period, but this was not the case. Other bias High risk Comment: high risk of bias because carry-over effect is not considered in this study and correlation between repeated measurements on the same individual is not considered in data analysis. Data prior to cross-over were not available. Methods Study objective: to compare the effects on pressure damage prevalence by using 2 different support systems in patients with fractured neck of femur who were at high risk • Description of interventions: a low-unit-cost system (Repose) ... comprising a low-pressure inflatable mattress and cushion that are readily portable and require little maintenance ... manufactured using a special polyurethane material that has a multidirectional stretch, is vapour permeable, waterproof and X-ray translucent • NPIAP S3I classification: non-powered, reactive air surface • Co-interventions: standard best practice as appropriate to condition, including regular repositioning • Number of participants randomised: n = 40 • Number of participants analysed: n = 24 at 14-day time point • Description of interventions: the system ... comprised a dynamic flotation mattress (Nimbus II) together with an alternating-pressure cushion for a chair (Alpha TranCell) ... The alternating pressure cushion is designed for use on a chair or wheelchair. • NPIAP S3I classification: powered, alternating pressure (active) air surface • Co-interventions: standard best practice as appropriate to condition, including regular repositioning Random sequence generation (selection bias) Low risk Quote: "a concealed computer generated list was used to randomise eligible consecutive consenting patients to one of the support systems" Comment: low risk of bias because of the use of a proper randomisation method. Allocation concealment (selection bias) Low risk Quote: "a concealed computer generated list was used to randomise eligible consecutive consenting patients to one of the support systems" Comment: low risk of bias because of a proper concealment method. Blinding of participants and personnel (performance bias) All outcomes Comment: high risk of bias because blinding was not possible for this comparison. Blinding of outcome assessment (detection bias) All outcomes Quote: "Patients were not assessed blindly as it was considered that displacement for examination would cause excessive discomfort. A team of trained researchers completed all assessments" Comment: high risk of bias because no blinding was done. Incomplete outcome data (attrition bias) All outcomes Quote: "No patient was excluded from all the analyses" Quote: "Data were not available for the 14-day follow-up assessment for a further 12 patients who were transferred to wards or hospitals that were not involved in the study or were discharged home" Comment: high risk of bias because 16 in Repose and 14 in NIMBUS II plus Alpha TranCell actually missed and were not included in analysis. Trusted evidence. Informed decisions. Better health. Selective reporting (reporting bias) Low risk Comment: the study protocol is not available but it is clear that the published reports include all expected outcomes, including those that were pre-specified. Other bias Low risk Comment: the study appears to be free of other sources of bias. Methods Study objective: to compare 3 mattresses in relation to patient pain, comfort and sleep disturbance Study design: randomised controlled trial, with a series design Study grouping: n-of-1 trial Single centre or multi-site: single centre Study start date and end date: not described Setting: Regional Rehabilitation Centre. Southern Birmingham Community NHS Trust. Inclusion criteria: all patients admitted to the unit (for patients with neurological disorders aged 16 to 65) with a Waterlow score of 15 and above, with no existing pressure sore or a sore of Grade 2 or lower visual analogue scale (VAS) used to indicate how comfortable a patient found the mattress; self-rated by patients • Definition: patient comfort ratings • Dropouts: 1 patient withdrawn due to clinical condition • Notes: 4 patients (10.3%) refused to be nursed on Nimbuss II and 20 (51.3%) on Pegasus Airwave because they found these mattresses too uncomfortable. One-way analysis of variance indicates that there are significant differences between the 3 mattresses in relation to comfort (F = 18.28, P < 0.01). Patients found Quattro DC2000 more comfortable than Nimbus II and Pegasus Airwave; this was significant (P < 0.01 in both cases). • Not reported • Not reported • Not reported Outcomes that are not considered in this review but reported in trials: • Random sequence generation (selection bias) Unclear risk Quote: "Patients were randomly allocated to one of three alternating-pressure mattress replacements." Quote: "The order in which patients used the mattresses was randomly allocated prior to admission to the study" Comment: unclear risk of bias because the sequence generation process was not described. Unclear risk Comment: no information provided. Blinding of participants and personnel (performance bias) All outcomes High risk Outcome group: all outcomes Quote: "Patients were not given information about the mattresses during the study but it was not possible to disguise the make of mattress" Comment: high risk of bias because non-blinding of patients is stated. Blinding of outcome assessment (detection bias) All outcomes High risk Outcome group: all outcomes Quote: "Patients were not given information about the mattresses during the study but it was not possible to disguise the make of mattress" Comment: high risk of bias because non-blinding of patients is stated and this affects the assessment of patient self-rated outcomes; pain and comfort. Incomplete outcome data (attrition bias) All outcomes Low risk Quote: "one patient was withdrawn from the trial due to her clinical condition" Comment: low risk of bias because the rate of dropout is low. Selective reporting (reporting bias) Low risk Comment: the study protocol is not available but it is clear that the published reports include all expected outcomes, including those that were pre-specified. Other bias High risk Comment: high risk of bias because the clustering issue probably occurs but is not addressed. Methods Interventions • Description of interventions: being a static mattress combined with a dynamic alternating system ... the foam is actually inside the alternating cells. The pump has a cycle of 10 minutes ... There is a CPR and static mode. It has an automatic pump that is also adjustable in two modes for patient comfort and 'dynamic use' (dynamic use refers to an alternating cell mattress driven by an electrical pump with air sacks which sequentially inflate and deflate to relieve pressure for short periods under the patient) ... the mattresses can be used as a static system when an alternating surface is not required. • NPIAP S3I classification: powered, alternating pressure (active) air surface; hybrid mattress (active and reactive modes) • Co-interventions: not described • Number of participants randomised: n = 5 • Number of participants analysed: n = 5 Softform Premier Active • Description of interventions: consists of a foam mattress with a dynamic underlay. The underlay alternates on a 2-cell 10-minute cycle time through the pump ... The pump is also able to assess the patient's weight and adjusts the supply of an appropriate level of air to provide an alternating surface ... the mattresses can be used as a static system when an alternating surface is not required. • NPIAP S3I classification: powered, alternating pressure (active) air surface; hybrid mattress (active and reactive modes) • Co-interventions: not described • Number of participants randomised: n = 5 • Number of participants analysed: n = 5 Random sequence generation (selection bias) Unclear risk Quote: "Patients considered to be at high risk of pressure ulcer development were randomly allocated ..." Comment: unclear risk of bias. Unclear risk Comment: no information provided. Blinding of participants and personnel (performance bias) All outcomes Comment: high risk of bias because it was unlikely to be possible to blind ward sta who were trained in using both systems for this study. Blinding of outcome assessment (detection bias) All outcomes Quote: "Their skin was assessed daily for any changes or development of pressure ulcers by ward sta and by the co-ordinator of the audit three times a week." Comment: high risk of bias because it was unlikely to be possible to blind ward sta . Incomplete outcome data (attrition bias) All outcomes All reported adverse events using allocated support surfaces • Notes: 1 death in this study but the authors did not specify which group the death was in; 3 participants withdrawn at 4 weeks due to worsened condition, all in overlay group • Not reported • Not reported Outcomes that are not considered in this review but reported in trials: • Ulcer healing • Time to ulcer healing Notes Cochrane Database of Systematic Reviews Random sequence generation (selection bias) Low risk Quote: "Randomization was performed by placing a number corresponding to each experimental condition into a sealed envelope with an equal number of envelopes per condition. A research assistant with no clinical experience drew envelopes by lot as eligible subjects were identified" Comment: low risk of bias because the sequence generation process seems proper. Allocation concealment (selection bias) Unclear risk Comment: no information provided. Blinding of participants and personnel (performance bias) All outcomes Unclear risk Comment: no information provided. Blinding of outcome assessment (detection bias) All outcomes Unclear risk Comment: no information provided. Incomplete outcome data (attrition bias) All outcomes Unclear risk Comment: unclear risk of bias because the dropout rates are low but are unbalanced (1 death is excluded from analysis and it is unclear which group the death is in; 3 participants withdrawn at 4 weeks due to worsened condition, all in overlay group). Selective reporting (reporting bias) Low risk Comment: the study protocol is not available but it is clear that the published reports include all expected outcomes, including those that were pre-specified. Other bias Low risk Comment: the study appears to be free of other sources of bias. Methods Study objective: to determine the efficacy and safety of a multi-cell pulsating dynamic mattress system in comparison with conventional management for the prevention of pressure ulcers in the operative and postoperative period in patients having cardiovascular surgery. Trusted evidence. Informed decisions. Better health. Inclusion criteria: be 18 years of age or older and be scheduled for cardiovascular surgery with general anaesthesia for at least 4 hours with an actual operative time of 3 hours or more Incomplete outcome data (attrition bias) All outcomes Quote: "Baseline characteristics and safety were evaluated for all randomised patients (i.e. intent-to-treat sample) ... The intent-to-treat sample included all patients who signed consent forms and who were placed either on a multi-cell pulsating dynamic mattress system or on a conventional mattress and had at least 1 day of observation post-surgery . .. An evaluable sample of patients was defined as patients who signed consent forms, had a surgery length of at least 3 hours, and had a minimum of 3 days of observation post-surgery ... One analysis included the intent-to-treat sample (multi-cell pulsating dynamic mattress system, n = 89; conventional management, n = 96)" Comment: low risk of bias because of the use of intention-to-treat (ITT) analysis. Selective reporting (reporting bias) Low risk Comment: the study protocol is not available but it is clear that the published reports include all expected outcomes, including those that were pre-specified. Other bias Low risk Comment: the study appears to be free of other sources of bias. Methods Study objective: to examine the effectiveness of a new overlay for at-risk patients who require head elevation Cochrane Database of Systematic Reviews Interventions Double-layer air-cell overlay • Reporting: not reported. Alternating pressure ( All reported adverse events using allocated support surfaces • Reporting: not reported. • Reporting: not reported. • Reporting: not reported. Random sequence generation (selection bias) Unclear risk Quote: "The subjects were randomly allocated to the groups by sequentially-labelled sealed envelopes." Comment: unclear risk of bias because the method of random number generation was not described. Unclear risk Quote: "The subjects were randomly allocated to the groups by sequentially-labelled sealed envelopes." Comment: unclear risk because it is unclear if the envelopes were opaque. Blinding of participants and personnel (performance bias) All outcomes Unclear risk Comment: no information provided. Blinding of outcome assessment (detection bias) All outcomes Unclear risk Comment: no information provided. Incomplete outcome data (attrition bias) All outcomes High risk Outcome group: all outcome (primary outcome) Comment: high risk of bias because 7 of 36 individuals randomised in double-layer group; 11 of 37 in single-layer group; and 8 of 35 in standard mattress excluded from analysis. Selective reporting (reporting bias) Low risk Comment: the study protocol is not available but it is clear that the published reports include all expected outcomes, including those that were pre-specified. Other bias Low risk Comment: the study appears to be free of other sources of bias. Methods Study objective: to compare Axtair One, an alternating pressure air mattress (APAM), with a viscoelastic foam mattress (VFM) in elderly patients at moderate to high risk of developing pressure ulcers (PUs). All reported adverse events using allocated support surfaces • Notes: the serious adverse events (SAEs) reported in the APAM group were 2 deaths, a massive septic shock with acute pulmonary oedema and a decompensation of an insulin-dependent diabetes. No SAEs were reported in the VFM group. There were 20 adverse events reported in each group, including 2 discomforts in the APAM group and 1 hyperalgesia in the VFM group. The other events did not involve the mattresses. • Reporting: not reported • Reporting: not reported Outcomes that are not considered in this review but reported in trials: • duration of bed rest • duration of sitting in a chair • frequency of preventative interventions Cochrane Database of Systematic Reviews • any therapeutic change Random sequence generation (selection bias) Low risk Quote: "Randomisation was centralised (RANDLIST software v1.2) and globally balanced intracentre with random block sizes established from two possibilities (2 and 4)" Comment: low risk of bias because of the use of a proper randomisation method. Allocation concealment (selection bias) Unclear risk Quote: "Randomisation was centralised (RANDLIST software v1.2) and globally balanced intracentre with random block sizes established from two possibilities (2 and 4)" Comment: unclear risk of bias because even though central randomisation was performed, the small block size means that the allocation in the subsequent block is predictable if a prior randomisation sequence has already been known. Blinding of participants and personnel (performance bias) All outcomes Incomplete outcome data (attrition bias) All outcomes Low risk Quote: "The population selected for the main analysis were all randomised patients in intention-to-treat (ITT)." Comment: low risk of bias because ITT analysis was performed. Selective reporting (reporting bias) Low risk Comment: the study protocol is not available but it is clear that the published reports include all expected outcomes, including those that were pre-specified. Other bias Low risk Comment: the study appears to be free of other sources of bias. Methods Study objective: to compare the pressure-reducing properties of 3 types of mattress overlays (water, alternating air, and static air mattress surfaces) as used with bed bound patients in a clinical setting Outcomes that are not considered in this review but reported in trials: • Interface pressure Random sequence generation (selection bias) Unclear risk Quote: "... subjects were randomly assigned to be placed on one of the three surfaces studied" Comment: unclear risk of bias because the method of randomisation was not specified. Unclear risk Comment: no information provided. Blinding of participants and personnel (performance bias) All outcomes Unclear risk Comment: no information provided. Blinding of outcome assessment (detection bias) All outcomes Unclear risk Comment: no information provided. Incomplete outcome data (attrition bias) Outcomes that are not considered in this review but reported in trials: • Interface pressure Random sequence generation (selection bias) Unclear risk Quote: "randomised controlled trial (efficacy data)" Comment: unclear risk because no information about randomisation method provided. Unclear risk Quote: "Upon recruitment, the data collector opened the next opaque envelope in sequence to reveal to which mattress group the subject should be allocated" Comment: unclear risk of bias because it is unclear if envelopes were numbered and sealed. Blinding of participants and personnel (performance bias) All outcomes Unclear risk Comment: no information provided. Blinding of outcome assessment (detection bias) All outcomes Unclear risk Comment: no information provided. Incomplete outcome data (attrition bias) All outcomes Low risk Outcome group: all outcomes (primary outcome) Comment: low risk of bias because no missing assumed. Selective reporting (reporting bias) Low risk Comment: the study protocol is not available but it is clear that the published reports include all expected outcomes, including those that were pre-specified. Other bias Low risk Comment: the study appears to be free of other sources of bias. Methods Study objective: evaluate the effectiveness of 2 devices, the Hill-Rom Duo mattress and the KCI Thera-Pulse Random sequence generation (selection bias) Low risk Quote: "... randomly assigned to either a Hill-Rom Duo mattress or a KCI Thera-Pulse bed" Quote: "Selection of an unmarked envelope from a pile of envelopes by sta unconnected with the study formed the randomisation process" Comment: low risk of bias because a proper randomisation method applied. Unclear risk Comment: "Selection of an unmarked envelope from a pile of envelopes by sta unconnected with the study formed the randomisation process" Comment: low risk of bias because it is likely that allocation was properly concealed. Blinding of participants and personnel (performance bias) All outcomes High risk Outcome group: all outcomes (primary outcome) Quote: "... unblinded randomised prospective trial" Comment: high risk of bias because it is clearly stated that this is an unblinded trial. Blinding of outcome assessment (detection bias) All outcomes Low risk Outcome group: all outcomes (primary outcome) Quote: "If the nurse in charge of the patient's care had a high level of suspicion that a pressure sore was present, the wound was digitally photographed. For study purposes, the digital photographs were anonymised and analysed subsequently by two independent Tissue Viability Nurses for confirmation of the existence of a pressure sore and assessment of severity" Comment: low risk of bias because efforts were made to minimise the risk of detection bias. Incomplete outcome data (attrition bias) Low risk Outcome group: all outcomes (primary outcome) Cochrane Database of Systematic Reviews All outcomes Comment: no attrition. Selective reporting (reporting bias) Low risk Comment: the study protocol is not available but it is clear that the published reports include all expected outcomes, including those that were pre-specified. Other bias Low risk Comment: the study appears to be free of other sources of bias. Methods Study objective: to provide data that will assist nurses in determining which mattress is the best choice for pressure sore prevention, and under which circumstances Cochrane Database of Systematic Reviews All outcomes Quote: "... the investigators, who assessed the patient and placed him/her in one of the two mattress groups" Comment: high risk of bias because it is likely the investigators performed this study. Blinding of outcome assessment (detection bias) All outcomes Quote: "In most cases patients were assessed by two investigators as a team, and occasionally by only one of the investigators" Quote: "The investigators who rated patient risk and evaluated skin condition knew the mattress assignment of each patient, making investigator bias possible" Comment: high risk of bias because non-blinding of outcome assessment is clearly stated. Incomplete outcome data (attrition bias) All outcomes Unclear risk Comment: no information provided. Selective reporting (reporting bias) Unclear risk Comment: no information provided. Other bias Unclear risk Comment: no information provided. Cochrane Database of Systematic Reviews Analysis 5.1. Comparison 5: Alternating pressure (active) air surfaces on operating tables and subsequently on ward beds compared with reactive gel surfaces on operating tables followed by foam surfaces on ward beds, Outcome 1: Proportion of participants developing a new pressure ulcer Total (95% CI) Total events: Heterogeneity: Tau² = 0.00; Chi² = 0.35, df = 1 (P = 0.55); I² = 0% Test for overall effect: Z = 2.39 (P = 0.02) Test for subgroup differences: Not applicable Sauvage 2017 • Serious adverse events: 2 deaths, a massive septic shock with acute pulmonary oedema and a decompensation of an insulin-dependent diabetes. • 20 adverse events, including 2 discomforts. • No serious adverse events reported • 20 adverse events, including 1 hyperalgesia. Events other than discomfort and hyperalgesia did not involve the mattresses. Refused to be nursed on Quattro DC2000: No data • Patient comfort ratings. Significant differences between the 3 mattresses in relation to comfort (one-way analysis of variance F = 18.28, P < 0.01). Quattro DC2000 more comfortable than Nimbus II and Pegasus Airwave (P < 0.01 in both cases). Data prior to cross-over of the n-of-1 trial were not available. Patients' opinions on the comfort aspects of Dyna-Form Mercury Advance: all 3 slept well Patients' opinions on the comfort aspects of Softform Premier Active: all 3 slept well • Patients' opinions on the comfort aspects of mattresses. Six of ten patients responded to the comfort questionnaire. • Patients rated perceptions of their comfort upon the mattress and their overall opinion of the support surface using Likert-type scales. Only one arm has data (18/22 completed the questionnaire). Overarching class of support surface (as used in this review) Powered/non-powered reactive air surfaces A group of support surfaces constructed of air-cells, which redistribute body weight over a maximum surface area (i.e. has reactive pressure redistribution mode), with or without the requirement for electrical power. Static air mattress overlay, dry flotation mattress (e.g. Roho, Sofflex), static air mattress (e.g. EHOB), and static mode of Duo 2 mattress. Powered/non-powered reactive lowair-loss air surfaces A group of support surfaces made of air-cells, which have reactive pressure redistribution modes and a lowair-loss function, with or without the requirement for electrical power. Low-air-loss hydrotherapy. Powered reactive air-fluidised surfaces A group of support surfaces made of air-cells, which have reactive pressure redistribution modes and an airfluidised function, with the requirement for electrical power. Air-fluidised bed (e.g. Clinitron). Non-powered reactive foam surfaces A group of support surfaces made of foam materials, which have a reactive pressure redistribution function, without the requirement for electrical power. Convoluted foam overlay (or pad), elastic foam overlay (e.g. Aiartex, microfluid static overlay), polyether foam pad, foam mattress replacement (e.g. Cochrane Database of Systematic Reviews MAXIFLOAT), solid foam overlay, viscoelastic foam mattress/overlay (e.g. Tempur, CONFOR-Med, Akton, Thermo). Alternative reactive support surfaces (non-foam or air-filled): reactive fibre surfaces Non-powered reactive fibre surfaces A group of support surfaces made of fibre materials, which have a reactive pressure redistribution function, without the requirement for electrical power. Silicore (e.g. Spenco) overlay/pad. Non-powered reactive gel surfaces A group of support surfaces made of gel materials, which have a reactive pressure redistribution function, without the requirement for electrical power. Gel mattress, gel pad used in operating theatre. Non-powered reactive sheepskin surfaces A group of support surfaces made of sheepskin, which have a reactive pressure redistribution function, without the requirement for electrical power. Australian Medical Sheepskins overlay. Non-powered reactive water surfaces A group of support surfaces based on water, which has the capability of a reactive pressure redistribution function, without the requirement for electrical power. Water mattress. A group of support surfaces made of air-cells, which mechanically alternate the pressure beneath the body to reduce the duration of the applied pressure (mainly via inflating and deflating to alternately change the contact area between support surfaces and the body; i.e. alternating pressure (or active) mode), with the requirement for electrical power. Alternating pressure-relieving air mattress (e.g. Nimbus II, Cairwave, Airwave, MicroPulse), large-celled ripple. Powered active low-air-loss air surfaces A group of support surfaces made of air-cells, which have the capability of alternating pressure redistribution as well as low air loss for drying local skin, with the requirement for electrical power. Alternating pressure lowair-loss air mattress. A group of support surfaces made of air-cells, which offer both reactive and active pressure redistribution modes, with the requirement for electrical power. Foam mattress with dynamic and static modes (e.g. Softform Premier Active). Alternating pressure (active) air surfaces A group of support surfaces made of air-cells, which offer both reactive and active pressure redistribution modes as well as a low-air-loss function, with the requirement for electrical power. Stand-alone bed unit with alternating pressure, static modes and low air-loss (e.g. TheraPulse). A group of support surfaces made of any materials, used as-usual in a hospital and without reactive or active pressure redistribution capabilities, nor any other functions (e.g. low air loss, or air-fluidised). Standard hospital (foam) mattress, National Health Service Contract hospital mattress, standard operating theatre surface configuration, standard bed unit and usual care. Cochrane Database of Systematic Reviews S20 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 S19 TI net bed* or AB net bed* S18 TI ( kinetic therapy or kinetic table* ) or AB ( kinetic therapy or kinetic table* ) S17 TI ( turn* bed* or tilt* bed* ) or AB ( turn* frame* or tilt* frame* ) S16 TI sheepskin OR AB sheepskin S15 TI water suspension or AB water suspension S14 TI air bag* or AB air bag* S13 TI air suspension or AB air suspension S12 TI alternat* pressure or AB alternat* pressure S11 TI static air or AB static air S10 Cochrane Database of Systematic Reviews • No blinding, but the review authors judge that the outcome measurement is not likely to be influenced by lack of blinding. • Blinding of outcome assessment ensured, and unlikely that the blinding could have been broken. Any one of the following. • No blinding or incomplete blinding, and the outcome measurement is likely to be influenced by lack of blinding. • Blinding of outcome assessment attempted, but likely that the blinding could have been broken. Any one of the following. • Insu icient information to permit judgement of low or high risk of bias. • The study did not address this outcome. Any one of the following. • No missing outcome data. • Reasons for missing outcome data unlikely to be related to true outcome (for survival data, censoring unlikely to be introducing bias). • Missing outcome data balanced in numbers across intervention groups, with similar reasons for missing data across groups. • For dichotomous outcome data, the proportion of missing outcomes compared with observed event risk not enough to have a clinically relevant impact on the intervention e ect estimate. • For continuous outcome data, plausible e ect size (di erence in means or standardised di erence in means) among missing outcomes not enough to have a clinically relevant impact on observed e ect size. • Missing data have been imputed using appropriate methods. Any one of the following. • Reason for missing outcome data likely to be related to true outcome, with either imbalance in numbers or reasons for missing data across intervention groups. • For dichotomous outcome data, the proportion of missing outcomes compared with observed event risk enough to induce clinically relevant bias in intervention e ect estimate. • For continuous outcome data, plausible e ect size (di erence in means or standardised di erence in means) among missing outcomes enough to induce clinically relevant bias in observed e ect size. • 'As-treated' analysis done with substantial departure of the intervention received from that assigned at randomisation. • Potentially inappropriate application of simple imputation. Any one of the following. • Insu icient reporting of attrition/exclusions to permit judgement of low or high risk of bias (e.g. number randomised not stated, no reasons for missing data provided). • The study did not address this outcome. Any of the following. • The study protocol is available and all of the study's prespecified (primary and secondary) outcomes that are of interest in the review have been reported in the prespecified way. • The study protocol is not available but it is clear that the published reports include all expected outcomes, including those that were prespecified (convincing text of this nature may be uncommon). Any one of the following. • Not all of the study's prespecified primary outcomes have been reported. • One or more primary outcomes are reported using measurements, analysis methods or subsets of the data (e.g. subscales) that were not prespecified. • One or more reported primary outcomes were not prespecified (unless clear justification for their reporting is provided, such as an unexpected adverse e ect). • One or more outcomes of interest in the review are reported incompletely so that they cannot be entered in a meta-analysis. • The study report fails to include results for a key outcome that would be expected to have been reported for such a study. Insu icient information to permit judgement of low or high risk of bias. It is likely that the majority of studies will fall into this category. The study appears to be free of other sources of bias. There is at least one important risk of bias. For example, the study: • had a potential source of bias related to the specific study design used; or • has been claimed to have been fraudulent; or • had some other problem. There may be a risk of bias, but there is either: • insu icient information to assess whether an important risk of bias exists; or • insu icient rationale or evidence that an identified problem will introduce bias 2 'Risk of bias' assessment in cluster-randomised controlled trials (cluster-RCTs) Recruitment bias (or identification bias) is the bias that occurs in cluster-RCTs if the personnel recruiting participants know individuals' allocation, even when the allocation of clusters has been concealed appropriately. The knowledge of the allocation of clusters may lead to bias because the individuals' recruitment in cluster trials is o en behind the clusters' allocation to di erent interventions; and the knowledge of allocation can determine whether individuals are recruited selectively. This bias can be judged through considering the following questions. • Were all the individual participants identified/recruited before randomisation of clusters? • Is it likely that selection of participants was a ected by knowledge of the intervention? • Were there baseline imbalances that suggest di erential identification or recruitment of individual participants between arms? Baseline imbalance between intervention groups can occur due to chance, problems with randomisation, or identification/recruitment bias. The issue of recruitment bias has been considered above. In terms of study design, the risk of chance baseline imbalance can be reduced by the use of stratified or pair-matched randomisation. Minimisation -an equivalent technique to randomisation -can be used to achieve better balance in cluster characteristics between intervention groups if there is a small number of clusters. Concern about the influence of baseline imbalance can be reduced if studies report the baseline comparability of clusters, or statistical adjustment for baseline characteristics. Similar to missing outcome data in individually randomised trials, bias can occur if clusters are completely lost from a cluster-RCT, and are omitted from the analysis. The amount of missing data, the reasons for missingness and the way of analysing data given the missingness should be considered in assessing the possibility of bias. Trusted evidence. Informed decisions. Better health. Alternating pressure (active) air surfaces versus reactive water surfaces Andersen 1982 Alternating-pressure air-mattress, more details not specified Water-filled mattresses, more details not specified All four studies (830 participants) reported this outcome and consistently showed that alternating pressure (active) air surfaces could reduce the proportion of participants developing a new pressure ulcer compared with the undefined 'standard hospital surfaces' (Andersen 1982; Bliss 1967; Laurent 1998; Sanada 2003) . Decubitus prophylaxis: a prospective trial on the e icacy of alternatingpressure air-mattresses and water-mattresses foam or transfoam):ti,ab,kw #4 overlay*:ti,ab,kw #5 "pad" or "pads":ti,ab,kw #6 "gel":ti,ab,kw #7 (pressure next relie*):ti,ab,kw #8 (pressure next reduc*):ti,ab,kw #9 (pressure next alleviat*):ti,ab,kw #10 Pressure Ulcer] explode all trees #24 (pressure next (ulcer* or sore* or injur*)):ti,ab,kw #25 (decubitus next (ulcer* or sore*)):ti,ab,kw #26 Copyright © 2021 The Authors. Cochrane Database of Systematic Reviews published by John Wiley & Sons, Ltd. on behalf of The Cochrane Collaboration Copyright © 2021 The Authors. Cochrane Database of Systematic Reviews published by John Wiley & Sons, Ltd. on behalf of The Cochrane Collaboration Copyright © 2021 The Authors conceived the review; designed the review; coordinated the review; extracted data; analysed or interpreted data; undertook quality assessment; performed statistical analysis; produced the first dra of the review conceived the review; designed the review; coordinated the review; analysed or interpreted data checked quality of statistical analysis; produced the first dra of the review; contributed to writing or editing the review; advised on the review; secured funding conceived the review; designed the review; checked quality of data extraction conceived the review; designed the review; checked quality of data extraction; checked quality assessment; checked quality of statistical analysis checked quality of data extraction; checked quality assessment Elizabeth McInnes: conceived the review; designed the review; coordinated the review; checked quality of data extraction; checked quality assessment Editor): edited the protocol; advised on methodology, interpretation and content; approved the final protocol prior to publication Sophie Bishop (Information Specialist): designed the search strategy and edited the search methods section Editorial Assistant): edited the reference section of the protocol and the review Chunhu Shi: I received research funding from the National Institute for Health Research (NIHR; Research for Patient Benefit, Evidence synthesis for pressure ulcer prevention and treatment, PB-PG-1217-20006). I received support from the Tissue Viability Society to attend conferences unrelated to this work. The Doctoral Scholar Awards Scholarship and Doctoral Academy Conference Support Fund (University of Manchester) also supported a PhD and conference attendance respectively Dumville: I am the Chief Investigator on a National Institute for Health Research grant that funded the conduct of this review (Research for Patient Benefit, Evidence synthesis for pressure ulcer prevention and treatment, PB-PG-1217-20006). This research was co-funded by the I am Co-investigator on a National Institute for Health Research grant that funded the conduct of this review (Research for Patient Benefit, Evidence synthesis for pressure ulcer prevention and treatment, PB-PG-1217-20006). This research was co-funded by the My previous and current employers received research grant funding from the NHS Research and Development Programme, and subsequently the NIHR, for previous versions of this review. The funders had no role in the conduct of the review. My previous employer received research grant funding from the NIHR for an RCT comparing di erent alternating pressure air surfaces for pressure ulcer prevention. This RCT (for which I was the Chief Investigator) is included in this review. I played no part in the data extraction or risk of bias assessment for this study The authors are grateful to the following peer reviewers who provided feedback on both the protocol and the review: Julie Bruce and Zena Moore. Thanks are also due to Denise Mitchell for copy-editing the protocol, to Jess Sharp for additional copyedit feedback, to Faith Armitage for copy-editing the review and to Nicole Pitcher for writing the Plain Language Summary.We also would like to thank Zhenmi Liu, Gill Norman and MelanieStephens for double-checking data extraction and risk of bias assessment for this review and Cochrane Musculoskeletal, Oral, Skin and Sensory Network Editors Peter Tugwell and Jennifer Hilgart for feedback and final approval of the review for publication. Time to pressure ulcer development • Reporting: not reported Support-surface-associated patient comfort • Reporting: not reported All reported adverse events using allocated support surfaces • Reporting: partially reported • Notes: approximately 1/2 of all participants in each group reported adverse events, with no differences between groups reported. All adverse events were related to the participant's condition; none were related to the multi-cell pulsating dynamic mattress system or conventional management support system. • Reporting: not reported • Reporting: not reported Random sequence generation (selection bias) Unclear risk Quote: "Before surgery, patients were randomly assigned to either the multi-cell pulsating dynamic mattress system or conventional management. Randomization was done blindly by using a sealed opaque envelope that contained the randomization information (i.e. multi-cell pulsating dynamic mattress system vs. conventional management)"Comment: unclear risk of bias because randomisation method is not described.Allocation concealment (selection bias) Unclear risk Quote: "Randomization was done blindly by using a sealed opaque envelope that contained the randomization information (i.e. multi-cell pulsating dynamic mattress system vs. conventional management)"Comment: unclear risk of bias because randomisation method is not described.Blinding of participants and personnel (performance bias) All outcomes Comment: high risk of bias because it is unlikely that participants were blinded, though no information provided.Blinding of outcome assessment (detection bias) All outcomes Quote: "Patients were examined immediately post-surgery for pressure ulcers, including number, stage (I to IV), size (area), location, and appearance. Patients were assessed daily for ... presence of pressure ulcers. A skin risk assessment was performed on days 1, 4, and 7 and on other days if a change in status was noted. Adverse events and concomitant medications were recorded daily"Comment: unclear risk of bias because information on outcome assessment is insufficient for a proper judgement. Alternating pressure air mattress (APAM)• Description of interventions: APAM (Axtair One, Asklé Santé, Nîmes, France) consisted of therapeutic air cells with a height of 12 cm, supplied by a compressor, which adjusts the pressure based on the patient's weight and whose mode of operation allows alternating inflation of 1 out of 2 cells, with a 6-minute cycle time. The study authors describe a random component in the sequence generation process such as referring to a random number table, using a computer random number generator, coin tossing, shu ling cards or envelopes, throwing dice, drawing of lots. The study authors describe a non-random component in the sequence generation process. Usually, the description would involve some systematic, non-random approach, for example, sequence generated by odd or even date of birth, sequence generated by some rule based on date (or day) of admission, sequence generated by some rule based on hospital or clinic record number. Insu icient information about the sequence generation process to permit judgement of low or high risk of bias. Participants and study authors enrolling participants could not foresee assignment because one of the following, or an equivalent method, was used to conceal allocation: central allocation (including telephone, web-based and pharmacy-controlled randomisation); sequentially numbered drug containers of identical appearance; sequentially numbered, opaque, sealed envelopes. Participants or investigators enrolling participants could possibly foresee assignments and thus introduce selection bias, such as allocation based on using an open random allocation schedule (e.g. a list of random numbers), assignment envelopes were used without appropriate safeguards (e.g. if envelopes were unsealed or non-opaque or not sequentially numbered), alternation or rotation, date of birth, case record number, any other explicitly unconcealed procedure. Insu icient information to permit judgement of low or high risk of bias. This is usually the case if the method of concealment is not described or not described in su icient detail to allow a definite judgement, for example if the use of assignment envelopes is described, but it remains unclear whether envelopes were sequentially numbered, opaque and sealed. Any one of the following.• No blinding, but the review authors judge that the outcome is not likely to be influenced by lack of blinding.• Blinding of participants and key study personnel ensured, and unlikely that the blinding could have been broken. Any one of the following.• No blinding or incomplete blinding, and the outcome is likely to be influenced by lack of blinding.• Blinding of key study participants and personnel attempted, but likely that the blinding could have been broken.• Either participants or some key study personnel were not blinded, and the non-blinding of others likely to introduce bias. Any one of the following.• Insu icient information to permit judgement of low or high risk of bias.• The study did not address this outcome.Cochrane Database of Systematic Reviews Data analyses, which do not take the clustering into account, in cluster-RCTs will be incorrect. Such analyses lead to a 'unit of analysis error' and over-precise results (too small standard error) and too small P values. Though these analyses will not result in biased estimates of e ect, they (if not correctly adjusted) will lead to too much weight allocated to cluster trials in a meta-analysis.Note that the issue of analysis may not lead to concern any more and will not be considered substantial if approximate methods are used by review authors to address clustering in data analysis. In the case that a meta-analysis includes, for example, both cluster and individually randomised trials, potential di erences in the intervention e ects between di erent trial designs should be considered. This is because the 'contamination' of intervention e ects may occur in cluster-RCTs, which would lead to underestimates of e ect. The contamination could be known as a 'herd e ect': that is, within clusters, individuals' compliance with using an intervention may be enhanced, which in return a ects the estimation of e ect. Alternating pressure overlay (with a 7.5-to 30minute cycle time) Pring 1998 Nimbus II (with a 10-minute cycle) Two comparators were used• Pegasus Airwave • Quattro DC2000 (operating in a one-in-four sequential cycle)Ra er 2011 Dyna-Form Mercury Advance (with a 10-minute cycle), consisting of the foam inside the alternating cells and being a static mattress combined with a dynamic alternating system Softform Premier Active, consisting of the foam inside the alternating cells and being a static mattress combined with a dynamic alternating system. Pegasus Trinova (an integrated dynamic mattress and chair cushion that have a static mattress in combina-Alternative dynamic mattress system (with a 10-minute cycle) Cochrane Database of Systematic Reviews tion with a dynamic alternating system, with a 7.5minute cycle)Theaker 2005 KCI TheraPulse bed (with low-air-loss feature), either applied at a 5-to 10-minute alternating pressure cycle or continuously staticHill-Rom Duo mattress, either applied at a 5-to 10-minute alternating pressure cycle or continuously staticAlternating pressure (active) air surfaces versus foam surfacesBliss 1995 Large cell Ripple bed (with a 10-minute interval of alternating pressure)Three types of foam mattresses, each as an arm:• Groove contoured foam overlay • Modular Propad • Preventix foam mattress.The characteristics (e.g. densities) of these foam were unspecified Alternating pressure air mattress (with a 7.5-to 30minute cycle time)High-specification foam mattress (high-density foam, and/or viscoelastic (memory) foam) • Two review authors independently assessed the titles and abstracts of the new search results for relevance using Rayyan rather than using Covidence. • For new included studies, one review author independently extracted data and another review author checked all data, rather than two review authors independently carrying out data extraction. • When a study only had complete case data, we considered complete case data in the related main analysis (i.e. assuming no missing data issue). This was not pre-planned. • We presented separate 'Summary of findings' tables for five of the six comparisons evaluated in this review. We did not present the table for the comparison between di erent types of alternating pressure (active) air surfaces. • Where we did not pool data, we conducted a GRADE assessment and presented these assessments in a narrative format in 'Summary of findings' tables. This was not previously planned.